[go: up one dir, main page]

WO2025069033A1 - Thérapie par champ électromagnétique et lumière directionnelle - Google Patents

Thérapie par champ électromagnétique et lumière directionnelle Download PDF

Info

Publication number
WO2025069033A1
WO2025069033A1 PCT/IL2024/050963 IL2024050963W WO2025069033A1 WO 2025069033 A1 WO2025069033 A1 WO 2025069033A1 IL 2024050963 W IL2024050963 W IL 2024050963W WO 2025069033 A1 WO2025069033 A1 WO 2025069033A1
Authority
WO
WIPO (PCT)
Prior art keywords
view
field
antenna
light
therapy device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/IL2024/050963
Other languages
English (en)
Inventor
Haim Amir
Tal Rachel HODADOV
Igal Zertser
Eran Vendriger
Sergey Meron
Sergey Zemliakov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Essence Security International ESI Ltd
Original Assignee
Essence Security International ESI Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Essence Security International ESI Ltd filed Critical Essence Security International ESI Ltd
Publication of WO2025069033A1 publication Critical patent/WO2025069033A1/fr
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0618—Psychological treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/002—Magnetotherapy in combination with another treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0622—Optical stimulation for exciting neural tissue
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/70—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0626—Monitoring, verifying, controlling systems and methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A61N2005/0663—Coloured light

Definitions

  • This document relates generally to stimulation of the human body, and more particularly, but not by way of limitation, to application of light therapy and electromagnetic field therapy to the human body.
  • Systems and methods are disclosed to provide and substantially align emitted light and electromagnetic radiation using a therapy device comprising at least one antenna in or on a housing configured to emit electromagnetic radiation according to an antenna field of view and one or more light sources in or on the housing configured to emit a visible light according to a light field of view.
  • systems and methods are disclosed to position an antenna and one or more light sources in or on a housing of a therapy device to substantially align emitted electromagnetic radiation from the antenna with emitted visible light from the one or more light sources substantially normal to and out of a first surface of the housing to provide electromagnetic radiation and emitted visible light to a user in a field of view of the therapy device, the field of view of the therapy device comprising the substantially aligned emitted electromagnetic radiation from the antenna and the emitted visible light from the one or more light sources.
  • systems and methods are disclosed to determine first and second parameters of a therapy output based at least in part on received user information and controlling generation of the therapy output concurrently having characteristics corresponding to the first and second parameters for a treatment interval.
  • the first parameter can include a color and the second parameter can include a stimulation waveform for generating the therapy output.
  • systems and methods are disclosed to determine a therapy output, including a visible light output signal, a non-visible electromagnetic wave output signal, and a treatment interval based at least in part on received user information, and to control concurrent generation of visible light and non-visible electromagnetic wave outputs by first and second sources for a treatment interval and adjustment of such outputs at one or more intermediate time periods of the treatment interval based at least in part on the received user information.
  • systems and methods are disclosed to determine first and second output signals, such as a visible light output signal and a non-visible electromagnetic wave output signal respectively, based at least in part on received user information and a predetermined relationship between the first and second output signals.
  • first and second output signals can be determined based on the received user information and the other of the first and second output signals can be determined using the predetermined relationship between the first and second output signals.
  • FIG. 1 illustrates an example system for providing concurrent generation of first and second therapy outputs.
  • FIG. 2 illustrates different first and second devices having different profiles.
  • FIG. 3 illustrates an example chart illustrating transitions between different sleep stages during patient sleep.
  • FIG. 4 illustrates an example sleep interval illustrating transitions between the different sleep stages.
  • FIG. 5 illustrates example brain activity of a patient during different states of consciousness.
  • FIGS. 6 and 7 illustrate example alpha waves of an electroencephalogram (EEG) signal.
  • EEG electroencephalogram
  • FIGS. 8 and 9 illustrates example signal modulation.
  • FIG. 10 illustrates an example method for providing concurrent first and second therapy outputs to a patient from one or more therapy devices for a treatment interval.
  • FIG. 11 illustrates example areas of a body.
  • FIGS. 12 and 13 illustrates example sleep protocols.
  • FIGS. 14, 15, 16 and 17 illustrate example therapy devices.
  • FIG. 18 illustrates an example layout of a printed circuit board (PCB).
  • PCB printed circuit board
  • FIG. 19 illustrates example measurements.
  • FIG. 20 illustrates a block diagram of an example machine upon which any one or more of the techniques (e.g., methodologies) discussed herein may perform.
  • Applied electric or magnetic potential and fields, and in certain examples, light can produce or encourage different biological functions in the human body.
  • Therapy refers to the application of energy, such as electromagnetic radiation, light, or combinations thereof, to a subject or patient.
  • alpha waves are neural oscillations ranging in frequency and amplitude that are typically associated with a relaxed but awake state of consciousness or mental state.
  • Application of alpha waves to a patient, in the form of electric or magnetic field potentials or other stimulation, can produce or encourage a relaxed mental state in the patient.
  • other electromagnetic fields can be applied to a patient to produce different biological functions or effects to the human body.
  • light therapy also known as phototherapy, is a type of treatment that involves exposure to specific wavelengths of light for therapeutic purposes.
  • Photons are particles of light or other electromagnetic radiation. The energy and type of electromagnetic radiation of photons are determined by frequency and wavelength.
  • the frequency of electromagnetic radiation generally, including light, refers to the number of wave cycles or oscillations that occur per unit time. In the context of light, frequency is measured in Hz and represents how rapidly the wave oscillates.
  • the wavelength of electromagnetic radiation generally, including light, refers to the distance between two corresponding points in a light wave, such as two adjacent crests or troughs, generally measured in meters or nanometers (nm).
  • the amplitude of electromagnetic radiation generally, including light, refers to the maximum displacement or height of a measured wave from its equilibrium position.
  • Light triggers various physiological processes that can have positive effects on the body. For example, light at least partially controls regulation of circadian rhythms.
  • the body internal clock also known as the circadian rhythm, regulates many physiological processes, including sleep- wake cycles, hormone production, and metabolism. Exposure to bright light during the day and darkness at night helps to keep the circadian rhythm in sync. Light can reset or impact circadian and other body rhythms, which can improve sleep quality, energy levels, mood, overall well-being, etc.
  • Exposure to different wavelengths, frequencies, magnitudes, or quantities of light produces different effects. For example, exposure to bright light has been shown to increase the production of serotonin, a neurotransmitter that regulates mood, sleep, and appetite. Low levels of serotonin are associated with depression, anxiety, and other mood disorders. By increasing serotonin levels, light therapy can help improve mood and reduce symptoms of depression and anxiety. In contrast, the lack of light increases production of melatonin, a hormone that promotes sleep, has antioxidant and anti-inflammatory properties, and regulates immune function.
  • Light therapy can additionally have anti-inflammatory effects on the body and improve skin health. Exposure to certain wavelengths of light can stimulate the production of cytokines, proteins that help regulate inflammation in the body. This can be particularly helpful for individuals with inflammatory conditions such as psoriasis or eczema. Exposure to other wavelengths of light can stimulate collagen production to reduce the appearance of fine lines and wrinkles.
  • the present inventors have recognized, among other things, that different combinations of concurrent visible and non- visible stimulation or therapy output, such as concurrent light and electromagnetic stimulation, etc., can be provided to a patient during and over specific time intervals and in specific orders to provide different biological effects, in certain examples mimicking natural biological patterns of the body that the body may or may not typically be exposed to in nature, such as application of one or more Solfeggio frequencies, specific brain waves or brain wave signals, etc.
  • visible can include human perceptible, such that visible stimulation or therapy output can include human perceptible stimulation or therapy output.
  • non-visible can include human imperceptible
  • non-visible stimulation or therapy output can include human imperceptible stimulation or therapy output, such as an output having a wavelength longer or shorter than visible light or the visible spectrum or changes (e.g., modulation changes) faster than those perceptible to a human eye.
  • the different biological effects can be selected by the patient and provided by one or more control circuits configured to control simultaneous or concurrent therapy (e.g., generation and application of therapy output) by different visible and non-visible energy sources (e.g., sources configured to emit, produce, or provide visible or non-visible energy).
  • first and second sources can be configured to provide stimulation by generating their respective outputs using respective signals, wherein the respective signals have a parameter or characteristic comprising the same frequency or respective first and second frequencies in the same range of frequencies based on received user information.
  • having the same frequency may comprise having an exact same frequency, but in other embodiments small differences of, for example, less than 10%, may be considered the same frequency. Such differences may arise from electronic tolerances, for example.
  • having the same frequency may comprise having the same solfeggio frequency.
  • having a characteristic comprised of a range of frequencies may comprise having a frequency band that spans the range, though not necessarily all at the same time.
  • the range of frequencies refers to frequencies present in a particular type of brain wave, e.g., alpha, beta, gamma, theta, or delta waves.
  • having a characteristic based the same range of frequencies may comprise a having a waveform corresponding to the same type of brain waves, in an embodiment.
  • having an output generated using signal that has a characteristic comprised of a frequency or a range of frequencies comprises the output having a waveform that has the frequency or the range of frequencies.
  • having an output generated using a signal that has a characteristic comprised of a frequency or a range of frequencies comprises the output having a waveform in which a carrier signal (e.g., a carrier wave having a carrier frequency) is modulated by a modulation signal (e.g., as described herein), wherein the modulation signal comprising the frequency or the range of frequencies.
  • a carrier signal e.g., a carrier wave having a carrier frequency
  • a modulation signal e.g., as described herein
  • more than one frequency range of range of frequency may be represented by the characteristic, for example a combination of solfeggio frequencies or a combination of brain waves or a combination or one or more solfeggio frequencies and one or more brain wave types.
  • the stimulation from the first and second sources may each be generated using respective signals that each has a characteristic comprising the same combination of frequencies and/or ranges of frequencies as each other.
  • the time interval for a stimulation or therapy program can include different stages having different intermediate time periods for the different stages within the time interval of the stimulation or therapy program, where the frequency or the range of frequencies provided can change, although in unison and concurrently with respect to the different stages and time periods.
  • the first and second sources can provide different frequency stimulation or therapy depending on the received user information and the determined or selected stimulation or therapy program.
  • the frequency of stimulation can, in certain examples, include the direct output of the visible or non-visible energy source.
  • an output of a source can include a carrier frequency (e.g., electromagnetic frequencies, such as 2.4 GHz, 5 GHz, 5.7- 5.8 GHz, etc., one or more frequencies or wavelengths of light, etc.) modulated by a stimulation frequency or a range of stimulation frequencies.
  • the modulation disclosed herein can include, among others, one or more of pulse-width modulation (PWM), amplitude modulation (AM), frequency modulation, or other modulation of a carrier wave.
  • PWM pulse-width modulation
  • AM amplitude modulation
  • frequency modulation or other modulation of a carrier wave.
  • an antenna or a magnetic coil can be configured to provide an output signal having a carrier frequency amplitude or frequency modulated to provide a first stimulation frequency or a range of stimulation frequencies.
  • an input signal to a light source can include a varying signal that results in a visible output signal that varies in amplitude or brightness according to a second stimulation frequency or a range of stimulation frequencies.
  • the first and second stimulation frequencies or range of stimulation frequencies can be the same, different, or combinations thereof, such as in different intermediate time periods of a treatment interval, etc.
  • FIG. 11 illustrates ten example areas of a body 1100, including: a first area (1) pelvis; a second area (2) reproductive organs; a third area (3) diaphragm; a fourth area (4) heart and lungs; a fifth area (5) neck and throat; a sixth area (6) brain; a seventh area (7) inner brain center; an eighth area (8) skull dome; a ninth area (9) arms and hands; and a tenth area (10) legs and feet.
  • the pelvic bones stabilize the feet on the ground.
  • the pelvis there are the uterus, rectum and bladder. These organs remove waste from the body and keep the internal environment of the body clean and healthy.
  • the second area (2) includes the reproductive organs and is associated with the ability to be fertile, have a healthy libido, and feel attractive.
  • the third area (3) includes the diaphragm and is connected to the many abdominal organs such as the pancreas, liver, spleen and kidneys, responsible for turning food into energy and removing waste from the body.
  • the fourth area (4) includes the heart and lungs and is the center that provides oxygen for all body and brain activities.
  • the fifth area (5) includes the neck and throat and is responsible for the ability to move the neck up, to the sides and down, which allows for spatial vision. In the throat are the vocal cords that allow us to express us to express our in speech. The arteries passing through the throat supply blood to both halves of the brain and allow all its activities. Cervical flexibility has a beneficial effect on concentration.
  • the sixth area (6) includes the brain which consists of two large halves that are divided into lobes. Together, they constitute the ability to gather information, remembering and analyzing the information signal to draw conclusions for the activation of the body. A healthy brain allows us to realize the potential inherent in us.
  • the seventh area (7) includes the inner brain center, including the limbic center of the brain, responsible for processing and producing emotions.
  • the eighth area (8) includes the skull dome, including the pineal gland, regulates the biological clock and circadian rhythm of the body, produces hormones, and regulates the body’s response to stress.
  • the ninth area (9) includes the arms and hands and is associated with creation, flexibility, and strength.
  • the tenth area (10) includes the legs and feet and is associated with stability of the body on the ground and motivation to live well.
  • the present inventors have further recognized that a selected color of visible light output can impact the effect of any applied stimulation or therapy output.
  • Different wavelengths of light in the visible spectrum produce different colors to the human eye.
  • the visible spectrum for the human eye ranges from approximately 400 to 700 nanometers (nm) in wavelength (or 400 to 700 terahertz (THz) in frequency). Light with a shorter wavelength appears blue or violet, while light with a longer wavelength appears red or orange. Green light falls in the middle of the spectrum, with a wavelength between 495 and 570 nm.
  • White light includes combinations of other colors.
  • the human eye perceives color through a complex process that involves specialized cells in the retina called cones. Different cones are sensitive to different wavelengths of light. Light enters the eye through the cornea, pupil, and lens, which focus the light onto the retina. The cones in the retina then convert the light into electrical signals that are transmitted to the brain via the optic nerve. The brain processes the signals from the cones to create the perception of color, as well as other factors such as the brightness and saturation of the light, the color of surrounding objects, the lighting conditions in the environment, etc.
  • the perception of different colors provides different physiologically responses to a patient that can depend on many factors, such as age, gender, health status, or other more specific or general factors.
  • different colors can produce different activation of the autonomic nervous system, which controls many involuntary bodily functions such as heart rate, blood pressure, and respiration.
  • other colors or quantity, brightness, or intensity of light or specific colors can produce the release of hormones and neurotransmitters in the brain.
  • Certain “warm” colors, such as red and orange tend to increase arousal and activity.
  • Other “cool” colors such as blue, green, or violet, tend to promote relaxation and calmness.
  • the present inventors have recognized, among other things, that the color of light can promote different physiologic processes in the body, and promote certain states, such that combinations of different types of waves and colors can beneficially impact the patient.
  • certain beneficial combinations can include, and in certain examples, can change with the frequency of electromagnetic field therapy, such as illustrated in Table 4.
  • exposure to bright light can stimulate the production of serotonin, a neurotransmitter that regulates mood and contributes to feelings of well-being.
  • exposure to darkness or dim light can stimulate the production of melatonin, a hormone that regulates sleep and helps to induce feelings of relaxation.
  • One example biological function is sleep. Sleep is a complex physiological process that involves many different parts of the brain. During sleep, the brain goes through different stages, each of which is characterized by different brain activity. Gamma, beta, and alpha waves are typically associated with an awake state. Gamma waves are generally associated with higher levels of cognitive processing, typically having a frequency between 25 and 100 Hz. Beta waves are generally associated with active, alert, and focused mental states, typically having a frequency between 12 and 30 Hz. Alpha waves are generally associated with a more relaxed but wakeful state, typically having a frequency between 8 and 12 Hz, but in certain examples between 8 and 13 Hz or between 7 and 14 Hz, etc.
  • brainwaves associated with sleep often include theta or delta waves.
  • Theta waves are associated with deep relaxation, meditation, and creativity, often observed during light sleep (e.g., the first stage of sleep), typically having a frequency between 4 and 8 Hz.
  • Delta waves are the slowest brainwave pattern and are associated with deep sleep (e.g., the third stage of sleep) and unconsciousness, typically having a frequency between 0.5 and 4 Hz.
  • Such beta, alpha, gamma, delta, and theta waves are often not regular sinusoidal waveforms, but waveforms ranging in frequency and amplitude within the respective ranges described above.
  • waveforms provided to the patient can include regular sinusoidal waveforms in the respective ranges described above, waveforms ranging in frequency and amplitude within the respective ranges described above, or in certain examples, specific waveforms that mimic waveforms recorded from the patient, one or more other patients, or clinical representatives of such respective waveforms. The order of and time spent in specific stages of sleep are important for healthy function.
  • a combination of different environments can be provided, such as using a combination of visible and non-visible stimulation or therapy output, in a specific order and duration to improve overall sleep function, to encourage appropriate transitions between sleep states given specific planned sleep or wake times, to encourage quality time in each sleep state, to assist patients in one or both of falling asleep or waking refreshed, improving general health and wellbeing.
  • sleep stimulation or therapy can be determined and provided to encourage specific phases or cycles of sleep for a patient.
  • a clinical, population-based, or patient- specific model of brain wave of expected or observed brain wave signals can be recorded or determined and used as a basis for determining and providing a sleep stimulation or therapy program to a patient, including one or more of visible and non-visible stimulation or therapy output.
  • such brain wave models can include variable frequencies within specific time periods, as opposed to a fixed frequency or frequencies for the specific time periods.
  • the provided stimulation or therapy can change as the brain changes states during sleep.
  • the brain state changes can be assumed based on expected change states during sleep, which may depend on one or more of an expected or determined time of sleep and a desired wake time.
  • Alpha waves are associated with a relaxed but awake state of consciousness or metal state.
  • a specific stimulation or therapy can include alpha wave stimulation or therapy by one or both of the first or second sources (e.g., visible or non-visible energy sources, etc.) during one or more of a pre-wake period before but including the desired wake time, a wake period starting at the desired wake time, etc.
  • the provided stimulation or therapy can change before sleep is expected, such as during a time period before an expected sleep time, for example, to encourage transition.
  • stimulation or therapy configured to relax or calm can be provided in the time period before the expected sleep time.
  • Exposure to specific light or patterns of light can produce or encourage different physiologic effects in the body. For example, exposure to a bright light (e.g., 1,000 lux, etc.) at a time prior to a desired sleep time (e.g., two hours prior, one hour prior, 30 minutes prior, 12 minutes prior, 6 minutes prior, etc.) and then a gradually decreasing quantity, brightness, or intensity of light (e.g., down to or less than 100 lux, single digits lux or less, zero, etc.) at or near the desired sleep time can encourage hormone production in a patient to encourage sleep.
  • Sunsets can take between 2 and 5 minutes (e.g., at 15 degrees per hour, etc.).
  • such exposure can be provided using a light therapy device.
  • quantity, brightness, or intensity of light can be determined or controlled with respect to lumens (i.e., a measure of visible light emitted from a light generator in all directions), power, voltage, current, or a percentage of maximum output of a respective light generator.
  • lumens i.e., a measure of visible light emitted from a light generator in all directions
  • power, voltage, current, or a percentage of maximum output of a respective light generator During sleep, for example, quantity, brightness, or intensity can be reduced from a first percentage output to a lower percentage output at different periods.
  • light quantity, brightness, or intensity can operate during a waking stage, after a night of sleep, at an upper level, and relative to that level may be reduced to an intermediate level (e.g., 50% or 33% or 67%, or roughly one of those percentages compared to the upper level) or a lower level (e.g., 10% or 5% or 20% or roughly one of those percentages compared to the upper level), etc.
  • light quantity, brightness, or intensity can vary depending on a color of the light output. For example, a light quantity, brightness, or intensity for the color blue for any of the level settings (e.g., low, intermediate, or high) may be less than the color red at the corresponding level setting.
  • the percentage change at the intermediate or lower level, relative to the upper level may differ for different colors.
  • the intermediate level for red may be 33% of the upper level for red
  • the intermediate level for blue may be 67 % of the upper level for blue.
  • the upper levels for the respective colors may correspond to different light quantities, brightness, or intensities.
  • a light intensity at the patient 0.5 meters from the light source, for the upper level for white light can be 3.1 lux and may vary for other colors, such as between 0.3 and 2.3 lux, etc.
  • a light intensity for the intermediate level for white light can be 1.6 lux and may vary for other colors, such as between 0.35 and 1.2 lux, etc.
  • a light intensity for the lower level for white light can be 0.5 lux and may vary for other colors, such as between 0.05 and 0.4 lux, etc.
  • the light quantity, brightness, or intensity can be one or more of: (1) lower in a sleep state or a sleep stage than in a waking stage or an awake state; (2) lower in a sleep state or a sleep stage than in a sleep-preparation phase or a preparation interval; and (3) lower in the sleep-preparation phase or the preparation interval than in the waking phase or the awake state.
  • visible therapy output may not change states or oscillate (e.g., does not oscillate colors or quantity, brightness, or intensity of visible stimulation or therapy) during sleep therapy, or at least during the portions of sleep therapy where the patient is supposed to be asleep and not waking up or preparing the patient to wake up.
  • a cool color can be provided having a relatively low quantity, brightness, or intensity (e.g., less than 20% of a light quantity, brightness, or intensity provided during waking, such as 10%, etc.), such as to promote relaxation and calmness, encourage a return to sleep, and confirm that non-visible stimulation or therapy is still being provided.
  • intermediate time periods during sleep stimulation or therapy can include transition of non-visible therapy stimulation or therapy output alone, without concurrent transition of the visible therapy stimulation or therapy output.
  • one or more of the Solfeggio frequencies can be provided in the time period before the expected sleep time, such as to promote a calming and soothing effect, a sense of safety and security, or inner peace, to aid the patient in falling asleep at or before the expected sleep time, or in certain examples, during a first time period after the expected sleep time.
  • a treatment interval can include a preparation interval before the expected sleep time and a sleep interval.
  • 528 Hz is particularly beneficial to start or end a therapy cycle, such as to prepare the patient to be receptive of additional or subsequent stimulation, or to leave therapy with a particular feeling of wellness.
  • 528 Hz can be used as an intermediate stimulation between two other stimulation frequencies to assist and improve the transition between other therapies.
  • the first 6 minutes of a therapy interval, or a first intermediate time period can include 528 Hz stimulation.
  • the second 6 minutes of the therapy interval, or a second intermediate time period can include 639 Hz stimulation.
  • 528 Hz promotes healing, inner peace, and connection
  • 639 Hz promotes harmony and enhances communication and empathy.
  • the combination of 528 Hz stimulation and 639 Hz stimulation to start a therapy session can be particularly effective.
  • different stimulation therapies are associated with different colors, as illustrated in Table 6, in addition to or separate from the different states of mind illustrated in Table 5.
  • FIG. 1 illustrates an example system 100 for providing concurrent generation of first and second therapy outputs, including light and electromagnetic field therapy, or visible and non- visible therapy, etc., based at least in part on received user information, such as from a patient or other user of the system 100.
  • the first and second therapy outputs can be provided to a patient for a treatment interval and can include concurrent adjustment of the first and second therapy outputs at one or more intermediate time periods of the treatment interval based.
  • One or more of the treatment interval, the intermediate time periods, or the concurrent adjustment of the first and second therapy outputs at the one or more intermediate time periods can be determined at least in part on the received user information.
  • the received user information can include information received from a user, such as the patient.
  • one or both of the duration of the treatment interval or the start time of the treatment interval can be determined at least in part on the received user information.
  • the duration of the treatment interval can be fixed and one or both of a start or an end time of the treatment interval can be determined at least in part on the received user information.
  • sleep therapy is one mode of the example system 100.
  • a general therapy such as to improve patient wellbeing or focus during awake time of the patient, such as during the morning, daytime, or evening prior to bed, can be provided, in certain examples, by oscillating or transitioning a color of light therapy concurrent with transitions with electromagnetic or non-visible therapy.
  • a treatment interval can include multiple intermediate intervals, and transitions can include at one, more than one, or each of the multiple intermediate intervals.
  • the treatment interval can include a selected interval, or in other examples a fixed treatment interval, such as during sleep or general therapy.
  • oscillating or transitioning the color of light therapy can be omitted from therapy provided while the person is sleeping or is scheduled to be sleeping.
  • the system 100 includes a control circuit 105 and a therapy source 110.
  • the therapy source 110 can include the control circuit 105.
  • the control circuit 105 can include one or a plurality of control circuits, such as first and second control circuits 106, 107, etc., such as to control one or more therapy sources, such as first and second sources 111, 112.
  • the therapy source 110 can include one or more stimulators, generators, or one or more other therapy sources, such as the first and second sources 111, 112.
  • the first source 111 can include the first control circuit 106 in a first device and the second source 112 can include the second control circuit 107 in a second device, separate from the first device.
  • one of the first or second control circuits 106, 107 can provide one or more timings or controls for the other, such as to control simultaneous or concurrent therapy or concurrent adjustment at one or more intermediate time periods of a treatment interval from a single device having both control circuits or separate first and second devices.
  • the control circuit 105 can be configured to receive information from or about a user, such as input 101 (e.g., a user interface, etc.) from a mobile device 102 or one or more other user interfaces or sources of information from or about the user.
  • the input 101 can include a selection or an indication of a selection of a particular program, one of a plurality of available programs, type of therapy, current state, desired state or benefit, total therapy time, area of the body,
  • the input 101 can include information from a database or profile of the patient, prescribed treatment or medication or directions from a clinician or other user or caregiver for the patient, etc.
  • the control circuit 105, or one or both of the first and second control circuits 106, 107, can be configured to determine a first and second output signals for concurrent stimulation or therapy output and a treatment interval for the first and second output signals based at least in part on the received input 101.
  • the therapy source 110 can include a signal generation circuit configured to generate a stimulation signal, such as a waveform having a frequency and amplitude, a carrier wave having a carrier frequency, a modulated carrier wave, or one or more other stimulation signals or waveforms.
  • the therapy source 110, or the first and second sources 111, 112 can include a first source configured to generate a first therapy output based at least in part on a determined first output signal and a second source configured to generate a second therapy output based at least in part on a determined second output signal.
  • the first source 111 can include an electromagnetic wave generator (e.g., including one or more of a generator or transmitter circuit, an antenna matching circuit, or a radiating element, such as an antenna, a magnetic coil, or one or more other conductors configured to transmit an electromagnetic wave, etc.) and the first therapy output can include a non-visible (e.g., outside of the visible spectrum perceptible by the human eye, such as outside of a visible range of 20 or 30 to 50 or 60 hertz, etc.) electromagnetic wave output.
  • an electromagnetic wave generator e.g., including one or more of a generator or transmitter circuit, an antenna matching circuit, or a radiating element, such as an antenna, a magnetic coil, or one or more other conductors configured to transmit an electromagnetic wave, etc.
  • the first therapy output can include a non-visible (e.g., outside of the visible spectrum perceptible by the human eye, such as outside of a visible range of 20 or 30 to 50 or 60 hertz, etc.) electromagnetic wave output.
  • the second source 112 can include a light generator (e.g., a light bulb, a light-emitting diode (LED), or one or more other light source, such as a display, a monitor, a projector, etc.) and the second output can include a visible light output (e.g., visible to the human eye).
  • a light generator e.g., a light bulb, a light-emitting diode (LED), or one or more other light source, such as a display, a monitor, a projector, etc.
  • the second output can include a visible light output (e.g., visible to the human eye).
  • the color output of certain light sources can depend on the material from which the light source was made.
  • Other light sources such as RGB sources, etc., are capable of providing different color outputs.
  • the quantity, brightness, or intensity of a light output (e.g., brightness, etc.) can depend on, among other things, a provided current.
  • a visible light output can be amplitude modulated to provide one or more therapy frequencies or range of therapy frequencies.
  • the modulation disclosed herein can include, among others, one or more of pulse-width modulation (PWM), amplitude modulation (AM), frequency modulation, or other modulation of the carrier wave.
  • PWM pulse-width modulation
  • AM amplitude modulation
  • the therapy frequencies or ranges of therapy frequencies can include one or more of: an alpha wave stimulation signal; a beta wave stimulation signal; a delta wave stimulation signal; a theta wave stimulation signal; one or more brain waves or signals representative of brain waves during one or more sleep stage; one or more Solfeggio frequencies; etc.
  • the visible and non-visible stimulation or therapy output can be provided, or application of such can begin, concurrently at a first time, such as at the beginning of a specific time interval, and optionally end concurrently at a second time, such as at the end of the specific time interval.
  • a first time such as at the beginning of a specific time interval
  • a second time such as at the end of the specific time interval.
  • the visible and non-visible stimulation or therapy output can be provided from a single device or generator having both the first and second sources.
  • such devices can be coordinated, such as by one or more control circuits, to provide the concurrent stimulation or therapy, such as each beginning to provide, emit, or apply a respective stimulation or therapy output at the first time and to end at the second time, with intermittent changes or transitions controlled by one or more control circuits during the specific time interval between the first and second times, such as at one or more intermediate time periods, etc.
  • the first and second sources 111, 112 although configured to provide different stimulations or therapies, can be configured to provide the same frequency or respective first and second frequencies in the same range of frequencies (e.g., substantially the same frequency, such as withing an error threshold, a threshold percentage relative to the desired frequency, etc.).
  • the visible stimulation or therapy output can include a specific carrier wave modulated by one or more stimulation frequency, such that, although providing a specific visible stimulation or therapy output at a visible wavelength or frequency, such visible aspect is a carrier wave including a modulated stimulation signal modifying the carrier wave to provide the benefit of the modulated stimulation signal.
  • the first and second sources 111, 112 can be configured to provide specific combinations of different frequencies to the patient, although with coordinated transitions during the treatment interval, including at one or more intermediate time periods, such as described herein.
  • FIG. 2 illustrates a diagram 200 showing different examples of a therapy source, including first and second devices 201, 202 having different profiles configured for placement in a bedroom (e.g., on a bedside table) to produce or encourage healthy sleep function in a patient.
  • the first and second devices 201, 202 can be configured for other locations or environments, such as for placement near a patient (e.g., within a threshold distance, in the same room, within a direct line of sight, etc.), optionally a minimum distance from the patient, in the time leading up to a desired sleep time, such as to promote a relaxed mental state prior to sleep to aid patient sleep quality and reduce the time for a patient to fall asleep.
  • the first and second devices 201, 202 can be configured for placement in locations where a patient is configured to remain for an extended period of time, such as an hour or more, including, for example, a desk, a couch or other chair, a vehicle, or one or more other locations.
  • one or more of the first and second devices can be positioned and used as a reading light, a night light, a table lamp, a room light, etc.
  • the therapy source can include the first device 201 (and not the second device 202), and the first device 201 can be configured to provide the visible and non- visible stimulation or therapy.
  • the first device 201 can be configured to emit a light visible to the patient.
  • the light can be modulated to provide both visible and non- visible stimulation to the patient.
  • the first device 201 can include a combination light and electromagnetic therapy device including a light therapy device and an electromagnetic therapy device, where the non-visible stimulation includes electromagnetic stimulation.
  • the therapy source can include a combination of separate components, such that the first device 201 includes a light therapy device and the second device 202 includes an electromagnetic therapy device, or vice versa.
  • sleep is especially important for overall brain health, such as providing time for the brain to remove toxins and waste products and strengthen the connections between neurons, improving learning, memory, and cognitive function.
  • FIG. 3 illustrates an example chart 300 illustrating transitions between different sleep stages during patient sleep.
  • REM rapid eye movement
  • NREM non-rapid eye movement
  • Stage one of NREM sleep is the first stage of sleep, typically characterized by slower and more irregular brain waves, including theta waves in the range of approximately 3 to 7 Hz.
  • Stage two of NREM sleep, or NREM2 303 is typically characterized by a decrease in body temperature with continued slowing brain activity having slightly higher amplitude including sleep spindles and K-complexes.
  • Stage three of NREM sleep, or NREM3 304 is the deepest stage of sleep, typically characterized by slow brain waves having deeper amplitude swings where the body is relaxed and most physical repair occurs, as well as the consolidation of memories.
  • REM sleep 305 the brain becomes more active, commonly characterized by rapid movement of the eyes back and forth, where most dreams occur and the body processes and consolidates emotional experiences and memories. The body becomes paralyzed during REM sleep 305, so as not to act out the dreams that occur.
  • a typically sleep cycle starts with a transition from an awake state 301 to a sleep state at NREM1 302, then NREM2 303, then NREM3 304, and often back to NREM2 303 before a first cycle of REM sleep 305.
  • Sleep cycles repeat every 90 to 120 minutes during the sleep interval, with later cycles having less time in NREM sleep but more time in REM sleep 305 until a patient wake time.
  • the progression of the different cycles can skip between different stages between successive REM sleep 305 segments.
  • FIG. 4 illustrates an example sleep interval 400 illustrating transitions between the different sleep stages during successive sleep cycles over a patient sleep interval, illustrated as a seven-and-a-half-hour sleep interval having four REM stages.
  • a preparation interval can precede the patient sleep interval, and the patient sleep interval can conclude with or be followed by a wakening or an awake interval.
  • an awake state is illustrated as stage zero (0).
  • the first awake state can include a preparation interval, such as in a time period prior to the patient sleep interval, during a time where the patient is scheduled to be asleep, etc.
  • the second awake state follows the patient sleep interval.
  • a wakening interval can precede or include a first portion of the second awake state.
  • one or more of an alarm or a visible light stimulation or therapy output configured to wake the patient can be provided during the wakening interval.
  • NREM1 as stage one (1)
  • NREM2 as stage two (2)
  • NREM3 as stage three (3)
  • REM as the REM stage.
  • Each of the four sleep cycles close with an REM stage.
  • the last NREM1 stage before the second awake state can be a fifth sleep cycle, after the end of the fourth REM stage.
  • Each successive REM stage in the sleep interval 400 has a longer duration than the previous REM stage.
  • the length and number of REM stages can vary.
  • the first sleep cycle in FIG. 4 starts with the first NREM1 for a first portion of the first hour of sleep, followed by NREM2 for a second portion of the first hour, NREM3 for a third portion of time, extending over the first hour, longer than the first two portions, before transitioning back to NREM2, then to the first REM stage between the first and second hours of sleep.
  • the second sleep cycle in FIG. 4 begins after the first REM stage and is similar to the first sleep cycle, closing with a longer second REM stage than the first REM stage after the third hour of sleep.
  • the third sleep cycle begins after the second REM stage and includes only NREM2 before transitioning to a third REM stage longer than the second REM stage.
  • the fourth sleep cycle begins after the third REM stage and again includes only NREM2 having a longer duration than the previous NREM2 before transitioning to a fourth REM stage.
  • the example sleep interval 400 closes with NREM1 before the second awake state after the sleep interval ends.
  • FIG. 5 illustrates example brain activity 500 (e.g., EEG waveforms, etc.) of a patient during different states of consciousness, from awake through REM sleep.
  • example brain activity 500 e.g., EEG waveforms, etc.
  • Drowsy brain activity 502 can include more regular, lower frequency, and higher amplitude brain waves than beta waves, including alpha waves between 8 and 12 Hz, but in other examples between 8 and 13 Hz or between 7 and 14 Hz, etc.
  • NREM1 brain activity 503 can include slower and more irregular brain waves, including example theta waves 510 in the between approximately 3 and 7 Hz.
  • a cycle of NREM1 often lasts only a few minutes (e.g., 6 to 10 minutes, etc.).
  • NREM2 brain activity 504 can include continued slowing brain waves, such as in contrast to NREM1 brain activity 503, having a greater amplitude variation and including sleep spindles 511 and K-complexes 512.
  • NREM2 is often a large percentage of total sleep time, accounting for up to 50% or greater of total sleep time in certain examples.
  • NREM3 brain activity 505 can include further slowing brain waves having deeper amplitude swings where the body is relaxed and most physical repair occurs, as well as the consolidation of memories. NREM3 often lasts for about 20 to 25% of total sleep time in certain examples.
  • one or more non-visible stimulation or therapy outputs directed to a particular portion of the body, such as selected by the patient or a user prior to therapy, in certain examples, according to Table 2, can be provided during NREM3.
  • REM brain activity 506 can include faster and lower-amplitude brain waves than most NREM brain waves, although including theta waves 510 similar to NREM1.
  • REM brain activity 506 is the most similar to awake brain activity 501 of the other sleep stages. However, due to paralysis, the patient does not typically move.
  • REM brain activity 505 often lasts for about 20 to 25% of total sleep time at different occurrences, with the duration of REM stages or cycles increasing as a patient sleeps.
  • the brain activity 500 illustrated herein can include template or clinical brain activity, such as one or more waveforms representative of a patient, a group of patients, or a patient population, etc.
  • the brain activity 500 can include recorded brain activity of a patient, such as using one or more electrodes to capture an EEG of the patient, etc.
  • one or more therapy outputs can be determined using the recorded, template, or clinical brain activity, such as a selected waveform for a therapy output, a frequency of a therapy output, a modulation frequency, a treatment interval, transitions between one or more intermediate time intervals, or one or more other therapy outputs or parameters.
  • recorded, template, or clinical brain activity such as one or more brain waves, types of brain waves, brain waves commensurate with specific sleep cycles, etc., can be stored in a waveform audio (WAV) file or one or more other formats.
  • the recorded, template, or clinical brain activity can be played back to the patient during a treatment session as a therapy output, or a stimulation signal can be determined using the recorded, template, or clinical brain activity.
  • WAV waveform audio
  • FIGS. 6-7 illustrate example time and frequency domain representations of an electroencephalogram (EEG) signal 600, 700, including an example alpha wave signal 601 in the time domain (T) and a frequency range of the alpha wave 701 in the frequency domain (Hz).
  • EEG electroencephalogram
  • Alpha waves are neural oscillations ranging in frequency and amplitude between 7 and 14 Hz (e.g., 8 to 12 Hz, 8 to 13 Hz, etc.) typically associated with a pleasant or deactivated state or feeling of calm, relaxed, serene, or content.
  • stimulation signals having the frequency of alpha waves e.g., an alpha-wave frequency range
  • a human-imperceptible stimulation signal can be modulated with an alpha-wave frequency range or other stimulation signal to provide a modulated stimulation signal that, when applied with the therapy source, can induce alpha waves in the patient, providing the benefit of alpha-wave stimulation without the patient perceiving the modulated stimulation signal.
  • the alpha waves described herein can include an alpha wave recorded from the patient or one or more other patients.
  • a digital representation of the alpha wave can be stored, such as in memory, and used, for example, as the biological or natural frequency stimulation signal, to provide the modulated stimulation signal. In this manner, the output of the therapy source includes a representation of the alpha wave.
  • the biological or natural frequency stimulation can alternatively include other neural oscillations, such as delta waves (e.g., 0.5 to 4 Hz), theta waves (e.g., 4 to 8 Hz), beta waves (e.g., 13 to 40 Hz), gamma waves (e.g., 40 Hz to 100 Hz), etc., to provide one or more other mental states associated with such waves.
  • delta waves are associated with deep sleep.
  • delta wave activity can be induced, such as to induce or increase a feeling of sleepiness in the patient or to improve sleep quality.
  • Theta waves are associated with various aspects of cognition and behavior, including learning, memory, and spatial navigation.
  • Beta waves are associated with active consciousness, including busy or anxious thinking and concentration.
  • Gamma waves are associated with processing complex tasks, important for learning, memory, and processing, and are used as a binding tool for senses to process new information.
  • Activity associated with each can be induced, such as to induce or increase feelings or activities associated therewith.
  • the amplitude of a high-frequency carrier wave can be modulated to carry a biological or natural stimulation frequency.
  • the amplitude of the carrier wave can be modulated to carry or otherwise include aspects of a first modulation signal, such that the resulting output is derived from, includes aspects from, or can otherwise be extrapolated from a combination of the carrier wave and the first modulation signal.
  • the amplitude of the carrier wave can be modulated, such as sweeping between first and second boundaries of a frequency range of the first modulation signal by a second modulation signal, etc., such as to produce an output signal, etc.
  • FIG. 8 illustrates example signal modulation 800 including modulating a carrier wave 801 by a stimulation signal 802 to produce a first and second example modulated stimulation signals 803, 804.
  • the carrier wave 801 has a constant carrier frequency and the stimulation signal 802 includes a simple sine wave having a constant, lower frequency than the carrier wave 801.
  • the modulation can include amplitude modulation.
  • the amplitude of the carrier wave 801 can be modulated by the stimulation signal 802 to produce the first example modulated stimulation signal 803.
  • the modulation to represent a signal in an output can be or include one or more other types of signal modulation, such as frequency modulation, pulse width modulation (PWM), etc.
  • the frequency of the carrier wave 801 can be modulated by the stimulation signal 802 to produce the second example modulated stimulation signal 804.
  • one or more stimulation types can be combined, such as amplitude modulation and PWM, frequency modulation and PWM, etc.
  • one or more of the carrier wave 801 or the stimulation signal 802 can include signals having changing amplitude or frequency.
  • the carrier wave 801 can be modulated across a first range of frequencies of a first stimulation signal, such as over an alpha-wave frequency range (e.g., between 7 Hz and 14 Hz), a range of or about a multiple of the Schumann resonance (e.g., 110 Hz to 112 Hz), etc.
  • the rate at which the modulation varies across the first range of frequencies can be controlled by a second stimulation signal, such as a frequency of the second stimulation signal, or across a second frequency range of the second stimulation signal.
  • the first stimulation signal can include a natural stimulation signal, such as a multiple of the Schumann resonance (e.g., 110 Hz to 112 Hz), and the second stimulation signal can include a biological stimulation signal, such as an alpha-wave signal (e.g., 10 Hz, 8 Hz to 13 Hz, 7 Hz to 14 Hz, etc.).
  • a natural stimulation signal such as a multiple of the Schumann resonance (e.g., 110 Hz to 112 Hz)
  • the second stimulation signal can include a biological stimulation signal, such as an alpha-wave signal (e.g., 10 Hz, 8 Hz to 13 Hz, 7 Hz to 14 Hz, etc.).
  • FIG. 9 illustrates example signal modulation 900 including modulating a carrier wave
  • the carrier wave 901 has a constant carrier frequency and the stimulation signal 902 includes a biological or natural frequency signal, in this example a complex signal representative of an alpha wave, varying in frequency and amplitude.
  • the stimulation signal includes a biological or natural frequency signal, in this example a complex signal representative of an alpha wave, varying in frequency and amplitude.
  • the stimulation signal includes a biological or natural frequency signal, in this example a complex signal representative of an alpha wave, varying in frequency and amplitude.
  • 902 can include one or more other biological or natural frequency signals.
  • the amplitude of the carrier wave 901 is modulated by the stimulation signal 902. In other examples, one or more other forms of modulation can be performed.
  • the carrier wave 901 can include one or more other signals of constant or varying amplitude, frequency, or other characteristic (e.g., square wave instead of sine wave, triangle wave, sawtooth wave, PWM signal, etc.).
  • FIG. 10 illustrates an example method 1000 for providing concurrent first and second therapy outputs to a patient from one or more therapy devices for a treatment interval.
  • user information can be received, such as using one or more control circuits.
  • the received user information can include information from the patient (e.g., when the user is the patient), a patient profile, or user information from one or more other users (e.g., when the user is not the patient, such as a user associated with the patient configured to receive or otherwise be exposed to the therapy output).
  • the user information can include or be indicative of a selection of a therapy or a therapy output by the patient or one or more other users.
  • the selection can include an indication of a selection of one of a plurality of available programs for electromagnetic or light therapy.
  • the selection can be a direct selection, such as through a user interface of a therapy device or one or a user interface coupled to or in communication with the therapy device (e.g., a mobile device, etc.).
  • the received user information can include a planned sleep or wake time of the patient, or information from one or more devices configured to detect a sleep state of the patient (e.g., a smart watch, a mobile device, etc.).
  • the user information can include information about a current state of the user (e.g., a current mood, feeling, etc.) or a desired state of the user.
  • one or more colors or questions can be provided to a patient for selection or feedback or other received user information.
  • a selection of a color by the patient can be received indicating a current state, mood, or feeling of the patient, or separately or in combination therewith, a selection of a color by the patient can be received indicating a desired state, mood, feeling, or effect of stimulation or therapy.
  • feedback can be received from the patient, such as in response to the one or more questions, separate from or in combination with a color selection.
  • the received user information (e.g., color, feedback, etc.) can be used to determine a stimulation or therapy program, such as one of a plurality of different available stimulation or therapy programs.
  • the received user information can be used to determine a combination of first and second outputs or output signals to be applied to the patient.
  • the received user information can be a patient selection of a specific program for a specific type of stimulation or therapy.
  • first and second outputs or output signals can be determined, including adjusting one or both of the first and second outputs or output signals at one or more intermediate time periods of a treatment interval based at least in part on the received user information, such as using at least one of the one or more control circuits.
  • the first and second outputs or output signals can include concurrent outputs or output signals, including concurrent adjustments of the first and second outputs or output signals at one or both of a beginning and an end of the treatment interval.
  • the first output can include a first therapy output from a first source and the second source can include a second therapy output from a second source.
  • the first source can include an electromagnetic wave generator configured to generate a non-visible electromagnetic wave output.
  • the second source can include a light generator configured to generate a visible light output.
  • at least one of the first and second outputs or output signals can be determined using the received user information and the other of the first and second outputs or output signals can be determined using a predetermined relationship between the first and second outputs or output signals.
  • the received user information can be a selected color.
  • the selected color can be used to determine the visible light output and a predetermined relationship between the respective visible light output and one or more of a plurality of non-visible electromagnetic wave outputs can be used to determine the non-visible electromagnetic wave output corresponding to the respective visible light output or the selected color.
  • the predetermined relationship can include a predefined correlation between a selected color and one or more frequencies or ranges of frequencies, such as illustrated in Tables 5 and 6, etc.
  • first and second outputs can include a modulated output.
  • an amplitude of a carrier wave can be modulated by a first modulation signal.
  • the first modulation signal can include a signal having a fixed or varying frequency or range of frequencies.
  • the modulation can include pulse-width modulation (PWM), frequency modulation, or combinations of two or more types of modulation.
  • PWM pulse-width modulation
  • the first modulation signal can be varied by a second modulation signal.
  • the second modulation signal can have a fixed or varying frequency or range of frequencies.
  • one or both of the first and second stimulation signals can be a biological or natural frequency stimulation signal, such as disclosed herein.
  • modulating the first stimulation signal about a single frequency, or across a range of frequencies can improve the likelihood that an effective stimulation signal is applied to the patient.
  • both the first and second stimulation signals are biological or natural frequency stimulation signals, the likelihood that the patient is positively affected is improved.
  • the first modulation signal can be varied randomly about a frequency or a range of frequencies.
  • one or both of the first and second outputs can be adjusted, such as using at least one of the one or more control circuits.
  • transition of the first and second outputs can be controlled at one or more intermediate time periods of the treatment interval.
  • the treatment interval can include at least one, but often multiple intermediate time periods, shorter than the full treatment interval, such as one or more subsets or sub-intervals of the treatment interval.
  • a first intermediate time period can start at the beginning of the treatment interval.
  • a second intermediate time period can end at the end of the treatment interval.
  • one or more intermediate periods can start or begin at various portions between but not including the beginning or end of the treatment interval (e.g., in the middle of the treatment interval).
  • One or more of the first output, the second output, the treatment interval, the intermediate time periods of the treatment interval, or concurrent adjustment of the first and second outputs at the one or more intermediate time periods can be determined or controlled using at least one of the one or more control circuits.
  • the first output can be provided, such as a non-visible electromagnetic wave from an electromagnetic wave generator using information from the one or more control circuits.
  • the second output can be provided, such as visible light output from a light generator using information from the one or more control circuits.
  • Therapy can be provided to a patient in proximity to one or more therapy devices configured to generate the first and second outputs over at least a portion of the treatment interval.
  • FIG. 12 illustrates an example sleep protocol 1200 including a preparation step (A), a main cycle step (B), and a wake-up step (C).
  • the main cycle step can repeat a number of times equal to the desired hours of sleep of the patient.
  • the total sleep time can include the preparation step and the wake-up step.
  • the total sleep time can be defined by the main cycle step with the preparation step and the wake-up step outside of the total sleep time.
  • preparation step can include two, six-minute portions, illustrated as a first portion (1) and a second portion (2).
  • the first portion can include an electromagnetic wave output at a first frequency (e.g., 528 Hz, etc.) and a visible light output having a first color (e.g., RGB (255, 150, 0), etc.)
  • the second portion can include an electromagnetic wave output at a second frequency (e.g., 639 Hz, etc.) and a visible light output have a second color (e.g., RGB (0, 255, 0), etc.).
  • the electromagnetic wave and visible light outputs can transition at the same or substantially the same times. In other examples, one or more other frequencies or colors can be provided.
  • the main cycle step can include a series of portions having the same or different lengths, but that can repeat a number of times depending on a desired length of sleep time of the patient.
  • the main cycle step can include a third portion (3) and a fourth portion (4) having lengths of nine minutes, and a fifth portion (5) having a length of fifteen minutes.
  • the third portion can include an electromagnetic wave output comprising theta waves
  • the fourth portion can include an electromagnetic wave output comprising delta waves
  • the fifth portion can include an electromagnetic wave output corresponding to a selected area of the body, such as received from the patient or one or more other users as received user information, such as commensurate with that described above with respect to Table 2 or FIG. 11.
  • the main cycle step can begin with the third portion, proceed to the fourth portion, then the fifth portion, third portion, fourth portion, and back to the third portion again, for a total of 60 minutes, before repeating, such as repeating a number of times equal to the number of hours the patient desires to sleep, such as received as user information.
  • the visible light output during the main cycle step can be held at a single color (e.g., RGB (204, 255, 204), etc.) at the lower level of quantity, brightness, or intensity so as not to wake or disturb the patient.
  • the visible light output can transition at one or more of the main cycle steps, such as during the fifth portion, etc.
  • the wake-up step can include a sixth portion (6) including an electromagnetic wave output comprising alpha waves.
  • the visible light output can remain at the same color as the main cycle step (e.g., RGB (204, 255, 204), etc.).
  • the quantity, brightness, or intensity of the visible light output can increase (e.g., greater than 20% of the upper level, etc.) to prepare the patient to wake up or assist in transition from sleep to awake, etc.
  • each of the portions described above and illustrated in FIG. 12 can be intermediate time periods, or sub-periods, of the treatment interval, or the time period at which one or both of electromagnetic wave or visible light output are provided to the patient.
  • the treatment interval can include the time period at which the electromagnetic wave output is provided to the patient, as a therapy device can, in certain examples, be used generally to provide visible light output separate from the electromagnetic wave output.
  • the intermediate time periods are sub-periods of the treatment interval.
  • FIG. 13 illustrates an example sleep protocol 1300 including a preparation step (A), a main cycle step (B), and a wake-up step (C).
  • the preparation step can include three, three-minute portions illustrated as a first portion (1), a second portion (2), and a third portion (3), followed by a fourth portion (4) having a length of six minutes.
  • the first portion can include an electromagnetic wave output at a first frequency (e.g., 528 Hz, etc.) and a visible light output having a first color (e.g., RGB (200, 70, 0), etc.).
  • the second portion can include an electromagnetic wave output at a second frequency (e.g., 639 Hz, etc.) and a visible light output having a second color (e.g., RGB (0, 255, 0), etc.).
  • the third portion can include an electromagnetic wave output at a third frequency (e.g., 174 Hz, etc.) and a visible light output having a third color (e.g., RGB (255, 0, 0), etc.).
  • the quantity, brightness, or intensity of the visible light output during the preparation step can include the same first quantity, brightness, or intensity (e.g., the intermediate level.) throughout the different portions.
  • the quantity, brightness, or intensity can decrease as the preparation step proceeds through one or more of the different portions, stepping down quantity, brightness, or intensity at transitions between one or more of the different portions or gradually throughout or during one or more of the portions of the preparation step.
  • the ninth portion can include an electromagnetic wave output at a ninth frequency (e.g., 528 Hz, etc.).
  • a ninth frequency e.g., 528 Hz, etc.
  • the first, seventh, and ninth frequency can include the same frequency (e.g., 528 Hz, etc.).
  • the visible light output can be held constant or be removed during one or more of the main cycle steps.
  • light quantity, brightness, or intensity can be held at a lower quantity, brightness, or intensity (e.g., the lower level) during the main cycle step than during one or both of the preparation and wake-up steps (e.g., the intermediate level, the upper level, etc.).
  • the visible light output of the seventh and ninth portions can be the same as the first portion of the preparation step, although at the lower quantity, brightness, or intensity.
  • the wake-up step can include a tenth portion (10) including an electromagnetic wave output comprising alpha waves.
  • the quantity, brightness, or intensity of the visible light output can increase (e.g., to the upper level), greater than the intensity of one or both of the preparation and main cycle steps.
  • FIGS. 14-15 illustrate perspective views
  • FIGS. 16-17 illustrate side views, of example therapy devices for providing concurrent generation of first and second therapy outputs, including light and electromagnetic field therapy, or visible and non-visible therapy, etc.
  • FIG. 14 illustrates a perspective view of an example therapy device 1400 including a housing 1401 having an interior space and a cover 1403 over a first surface (e.g., a front face) of the housing 1401 configured to enclose, when engaged with the first surface of the housing 1401, the interior space of the housing 1401.
  • the housing can optionally include a base 1402 to support the housing 1401 (e.g., on a horizontal surface, etc.).
  • the cover 1403 can include an edge 1404 with a transition 1405 (e.g., a curve) between a major exterior surface 1406 of a central body and the edge 1404.
  • the transition 1405 can be a component of the major exterior surface 1406.
  • the transition 1405 can be a component of the edge 1404 or a component separate from the edge 1404 and the major exterior surface 1406.
  • the housing 1401 can comprise an opaque metal or plastic material. However, at least a portion, and optionally all, of the central body of the cover can be translucent (e.g., a translucent plastic or glass material) to allow light from one or more light sources in the housing 1401 to be emitted therethrough, such that the light is at least visible, and in certain examples very bright, to the user.
  • the central body of the cover can be translucent while the remaining elements of the cover 1403, such as the edge 1404 and the transition 1405, can be opaque.
  • at least a portion of one or more of the edge 1404, the transition 1405, or the central body of the cover can be translucent to allow light to be emitted therethrough.
  • the central body may disk-shaped.
  • the central body may comprise a transparent wall that may form an outer wall of the body.
  • the transparent wall may consist of polycarbonate, for example.
  • the transparent wall may act as a lens.
  • the planar body may further comprise diffusing wall that may for an inner wall of the body.
  • the diffusing wall may for consist of a diffusing material (e.g., a diffusing powder) mixed with a transparent material, as is known in the art.
  • the diffusing wall may have an opacity of more than 80%, or more than 90%. The opacity may be less than 95%. In an embodiment the opacity is 92%.
  • the therapy device 1400 includes a major stimulation axis 1407 substantially perpendicular to a surface of the cover 1403.
  • the major stimulation axis 1407 can be substantially perpendicular (e.g., within a threshold tolerance) to the surface of the cover 1403.
  • the major stimulation axis 1407 can be parallel with a bottom surface of the base 1402.
  • the therapy device 1400 can include first and second sources, such as an electromagnetic wave generator (e.g., an antenna) and a light generator (e.g., one or more light sources), designed to provide and substantially align first and second therapy outputs along the major stimulation axis 1407, such that the first therapy output is substantially coextensive with the second therapy output.
  • first and second sources such as an electromagnetic wave generator (e.g., an antenna) and a light generator (e.g., one or more light sources), designed to provide and substantially align first and second therapy outputs along the major stimulation axis 1407, such that the first therapy output is substantially coextensive with the second therapy output.
  • the therapy device in addition to substantially aligning the first and second therapy outputs (e.g., within an alignment threshold, such as ⁇ 5 degrees, ⁇ 2 degrees, etc.), such as with respect to a horizontal plane of the major stimulation axis, the therapy device can be configured to control or adjust fields of view of the first and second therapy outputs, such that a light field of view of the therapy device 1400 (e.g., a beam angle of a light output) is substantially the same as an antenna field of view of the therapy device 1400 or that the light field of view is within or specifically greater than a threshold tolerance (e.g., 20%, 10%, etc., or separately in terms of degrees, such as 20 degrees, 10 degrees, etc.) of the antenna field of view.
  • a threshold tolerance e.g. 20%, 10%, etc., or separately in terms of degrees, such as 20 degrees, 10 degrees, etc.
  • the therapy device 1400 can include a first source configured to provide visible and non-visible therapy, such as a modulated light output having visible and non- visible aspects (e.g., a light output including non-visible changes, etc.).
  • a modulated light output having visible and non- visible aspects e.g., a light output including non-visible changes, etc.
  • FIG. 15 illustrates a perspective view of an example therapy device 1500, including the elements described in FIG. 14, however, additionally illustrating a location of a printed circuit board (PCB) 1408 in the housing 1401 including one or more light sources (e.g., one or more light emitting diodes (LEDs), such as surface mount or integrated circuit LEDs, etc.).
  • a printed circuit board PCB
  • LEDs light emitting diodes
  • a light field of view of the therapy device 1500 (e.g., a measurement in degrees with respect to the major stimulation axis 1407 in which a light provided by the therapy device 1500 is visible to an observer, a beam angle of the therapy device 1500, etc.) can be determined by one or more of: a field of view or beam angle as an inherent property of the one or more light sources or a package of the one or more light sources; positions of the one or more light sources on the PCB 1408; a position of the PCB 1408, such as a depth of the PCB 1408 in the housing 1401, in relation to one or more of a front edge of the housing 1401 adjacent the edge 1404 of the cover 1403, the edge 1404, the transition 1405, or one or more light isolation elements; or combinations thereof.
  • the light field of view or beam angle of the therapy device 1500 (e.g., viewed from above) can be greater than 120 degrees (e.g., between 120 and 155 degrees, between 132 and 155 degrees, such as 150 degrees, etc
  • the light field of view can be calculated as a full- width half maximum (FWHM) of the therapy device 1500 (e.g., the one or more light sources, etc.), 50% of a maximum point of light density output from the therapy device 1500.
  • FWHM full- width half maximum
  • one or more other thresholds can be determined, such as 25% of the maximum point of light density output, etc.
  • the maximum point of light density output can be substantially commensurate with the major stimulation axis 1407 or within a threshold thereof.
  • a user may see that the light is on, such as viewing light dispersed by the therapy device 1500 on one or more surfaces, if the user cannot directly see the light (e.g., a lit portion of the major exterior surface 1406, etc.), the user is outside the light field of view.
  • an opaque material can be added to a surface of the edge 1404 or the transition 1405.
  • the edge 1404 or transition 1405 may be indirectly lit, such as to provide an indication to the user that the light is on (and that therapy is being provided), but at a different intensity than through the cover 1403.
  • the cover 1403 can include one or more diffusers or may otherwise be configured to diffuse the light from the one or more light sources, such as using one or more shapes or physical properties (e.g., a textured surface, etc.) of the cover 1403 to scatter, soften, deflect, or reflect light as it passes through the cover 1403.
  • a separate diffuser can be included underneath the cover 1403.
  • the PCB 1408 can include the one or more light sources and an antenna (e.g., a patch antenna or one or more other directional antennas, etc.).
  • both of the light field of view and the antenna field of view of the therapy device 1500 can have the same relative range or value, such as greater than 90 degrees, between 90 and 155 degrees, between 100 and 120 degrees, between 120 and 155 degrees, etc.), such that a user within the field of view (with respect to the major stimulation axis 1407) of the therapy device 1500 is exposed to both light and radio frequency therapy while each are provided by the therapy device 1500.
  • the frequency of the electromagnetic field therapy e.g., a carrier frequency, etc.
  • the field of view of the therapy device 1500 can include one or both of the light field of view and the antenna field of view of the therapy device 1500 (e.g., one of, a union of, or an intersection of the light field of view and the antenna field of view, etc.).
  • the field of view for an antenna can include a field of view with respect to a major lobe of a main beam of radio frequency radiation having exposure to radiation above a threshold therapy tolerance (e.g., -3 dB beamwidth (BW), i.e., the field of view of the antenna can be defined as the half-power beamwidth (HPBW) of the radiation pattern).
  • a threshold therapy tolerance e.g., -3 dB beamwidth (BW)
  • HPBW half-power beamwidth
  • One or more control circuits can limit the radiation a user is exposed to using the HPBW and the efficiency (or peak power) of the antenna, such as by controlling the transmit power of a transmitter coupled to the antenna, etc.
  • the power provided to users can be within safety limits set by one or more organizations (e.g., FCC limit for public exposure of 1.6 watts per kilogram (W/kg) or one or more other limits, such as 10 uW/m 2 , 0.05 V/m, etc.).
  • the shape of the major lobe of the main beam can be impacted by other components of the therapy device, such as power electronic components (e.g., HV capacitors, etc.), one or more processors or processing circuits or components thereof (e.g., heat sinks, regulators, etc.), etc.
  • the major lobe can refer to the major lobe of the antenna without consideration of other components of the therapy device (e.g., of the antenna alone), or separately, the major lobe of the antenna can refer to the major lobe with consideration of other components of the therapy device (e.g., of the antenna in the finished therapy device after consideration of all interference of such packaging and other components, etc.).
  • the light field of view can be specifically larger (e.g., within a threshold) than the antenna field of view, such that the field of view of the light can indicate an upper limit of exposure to radio frequency therapy (e.g., above a threshold therapy tolerance), but more importantly, that lack of exposure to the field of view of the light can indicate a position of the user (outside of the light field of view) outside the antenna field of view, in a location having exposure to the radio frequency therapy below the threshold therapy tolerance, in certain examples, defined at least in part by one or more of a transmit power of a transmitter coupled to the antenna, one or more aspects of the matching network, or the HPBW.
  • the light field of view can be greater than 120 degrees (e.g., between 132 and 155 degrees, such as 150 degrees, etc.).
  • the antenna field of view e.g., above a threshold therapy tolerance
  • the antenna field of view can be less than the light field of view, such that the antenna field of view is less than and not overlapping with the light field of view.
  • the antenna field of view when viewed from above, can be between 90 and 130 degrees horizontally.
  • the antenna field of view can be larger vertically (when viewed from a side) than horizontally (in some examples greater than 130 degrees, including 150 degrees, etc.), such as to account for placement on surfaces having varying height with respect to a user.
  • FIGS. 16-17 illustrate side (and slightly elevated) views of an example therapy devices 1600, 1700, including the elements with the same or similar descriptions as corresponding elements described in one or more of FIGS. 14-15.
  • FIG. 17 illustrates an optional light isolation sleeve 1409 configured to control emission of light and ensure that light is not emitted through the top and bottom of the housing 1401, the edge 1404, or a portion of the transition 1405 or the cover 1403 until desired.
  • FIG. 17 additionally includes an optional separate optical diffuser 1410 underneath and separate from the cover 1403 to scatter, soften, deflect, or reflect light emitting from the therapy device 1700.
  • FIG. 18 illustrates an example layout 1800 of a front surface of a PCB 1801 for a therapy device including one or more light sources (e.g., one or more LEDs, such as a plurality of LEDs LD1-LD24, etc.) and an antenna 1802.
  • the antenna 1802 can include a patch antenna, in certain examples printed or otherwise positioned on the PCB 1801, such as centrally located (e.g., printed) on the front surface of the PCB 1801, such as not to interfere with dispersal of light by the one or more light sources.
  • the antenna 1802 can include a feed across a gap to a larger ground plane (e.g., represented by the square outside of the antenna 1802). To maintain a wide field of view, a single patch antenna may be used, such as opposed to an array of patch antennas or a stacked patch antenna, etc.
  • the one or more light sources can be arranged in various configurations, such as in three rings of 8 light sources (e.g., a first ring 1803 including LD1-LD8, a second ring 1804 including LD9-LD16, and a third ring 1805 including LD17-LD24, etc.), providing a substantially uniform distribution about the antenna 1802.
  • the PCB 1801 can include more or less light sources, however, still providing uniform or substantially uniform distribution (e.g., within a threshold percentage, such as 5%, etc.) with respect to one or more planes normal to the major stimulation axis of the antenna 1802.
  • the PCB 1801 can include one or more ground planes for the antenna 1802, such as located on one or both sides of the PCB 1801 (e.g., with or opposite, but preferably at least opposite, the one or more light sources and the antenna 1802).
  • Each individual light source has an independent principal axis (e.g., an axis central and normal to the individual light source, for example, at the center of a beam angle, etc.).
  • the principal axis of the one or more light sources e.g., LD1-LD24
  • each ring of the one or more light sources is substantially aligned with a major stimulation axis of the antenna 1802.
  • the composite field of view or beam angle of the one or more light sources are an aggregate of the field of view or bean angle of each of the respective plurality of light sources.
  • each of the plurality of LEDs LD1-LD24 include packaging having a height from the surface of the front surface. A requirement that the remaining components on the front surface of the PCB 1801 can be imposed to minimize interference of emitted light.
  • no component on the front surface of the PCB 1801 has a height greater than 5mm, or in another embodiment, 2mm. In an embodiment, there is no component on the front surface of the PCB that is taller than a height of any of the plurality of LEDs.
  • power electronic components, driver circuits, or one or more components having dense conductive material can be required to be placed on the back surface of the PCB 1801, such as to reduce interference with electromagnetic radiation emitted from the antenna 1802 and visible light emitted from the one or more light sources.
  • such components can be located away from the center of the PCB on the back surface (e.g., opposite the antenna 1802 and in certain examples the isolation region between the antenna 1802 and the ground plane illustrated on the front surface) and in certain examples additionally balanced (e.g., by density of conductive material, by current density, etc.) about the back surface to further reduce interference with antenna performance.
  • a tallest component on the back of the PCB 1801 is taller than a tallest component on the front of the PCB 1801.
  • no component on the back of the PCB 1801 has a height greater than 10mm.
  • the components on the back of the PCB 1801 may include one or more or all of a voltage-controlled oscillator for generating a non-visible electromagnetic wave carrier frequency as described herein, a supercapacitor, and/or an inductor.
  • FIG. 19 illustrates example measurements 1900 for a therapy device 1901 (e.g., illustrative and not necessarily according to scale) with respect to a major stimulation axis 1902, the measurements including an antenna field of view 1903 having a first angle 1904 and a light field of view corresponding to a second angle 1905 (e.g., between 130 and 155 degrees, such as 150 degrees, etc.), substantially similar to or greater than the first angle 1904.
  • the example measurements 1900 illustrated in FIG. 19 are with respect to the antenna and the one or more light sources, without consideration of interference from other electronics of a finished therapy device (e.g., power electronics, driver circuits, amplifiers, regulators, processors or processing circuits, memory devices, etc.).
  • a finished therapy device 1901 including all components can produce field variation differences, such as by interference with the theoretical or tested electromagnetic radiation introduced by other conductors or electric or magnetic fields in the housing of the therapy device 1901 (e.g., heat sinks for electronic components, etc.).
  • the first and second angles 1904, 1905 can be between 90 and 155 degrees. In another example, the first angle 1904 can be 120 degrees and the second angle 1905 can be 150 degrees. In other examples, the first and second angles 1904, 1905 can include one or more other angles. In certain examples, the range (e.g., distance) of the antenna field of view 1903 can be dependent upon, among other things, one or more of a transmitter or signal generator power provided to the antenna, electrical characteristics of a matching circuit, the presence of a ground plane or other shielding elements, etc.
  • the therapy device 1901 can additionally have a back field of view 1906.
  • the front-to-back ratio of the strength of the electromagnetic field radiated along the major stimulation axis 1902 compared to that radiated in the back direction e.g., a front-to-back power ratio
  • the front-to-back ratio of the strength of the electromagnetic field radiated along the major stimulation axis 1902 compared to that radiated in the back direction can be greater than 10-to-l, or in certain examples even greater (e.g., 12-, 13-, 14-to-l, etc.).
  • the example measurements 1900 described herein are based on testing of a centrally- located printed 5.8 GHz patch antenna on a PCB (such as illustrated in FIG. 18) in the therapy device 1901 (such as illustrated in FIGS. 14-17), providing an antenna efficiency of 30.9% ( ⁇ 10%) (e.g., 30.9 mW, 14.9 dBm, -5.1 dB, 1 dBi, such as from a lOOmW signal generator), a horizontal (azimuth, as viewed from above) antenna field of view (e.g., -3 dB BW, HPBW, etc.) of 120 degrees relative to the major stimulation axis 1902, a vertical (elevation, as viewed from the side) antenna field of view (e.g., -3 dB BW, HPBW, etc.) of 150 degrees relative to the major stimulation axis 1902, a voltage standing wave ratio (VSWR) of 3.0:1 (controlled by the antenna and the matching circuit, which can be selectively detune
  • one or more parameters or measurements described or illustrated herein can depend on various factors, such as environmental factors, etc. (e.g., the surface on which the therapy device 1901 is located at the time of therapy, etc.).
  • positioning the therapy device 1901 on a metal ground plane can provide a reduced horizontal (azimuth, as viewed from above) antenna field of view (e.g., -3 dB BW, HPBW, etc.) of 100 degrees relative to the major stimulation axis 1902 and a reduced vertical (elevation, as viewed from the side) antenna field of view (e.g., -3 dB BW, HPBW, etc.) of 120 degrees relative to the major stimulation axis 1902.
  • the threshold tolerance, alignment, or other parameters or measurements described herein are described with respect to the therapy device resting on a wood or plastic surface and operating in substantially free space, without impeding environmental factors.
  • the vertical (elevation, as viewed from the side) antenna field of view can be greater than the horizontal (azimuth, as viewed from above) antenna field of view.
  • the vertical antenna field of view can be greater than the light field of view, which can be substantially similar in the azimuth and elevation directions.
  • the light field of view of the therapy device 1901 can be the same as or in certain examples specifically greater than the antenna field of view of the therapy device 1901 when considered from the azimuth direction (e.g., horizontally, as viewed from above, a horizontal plane with respect to the base along the major stimulation axis), but not the elevation direction (e.g., vertically, as viewed from the side, a vertical plane with respect to the base along the major stimulation axis).
  • the azimuth direction e.g., horizontally, as viewed from above, a horizontal plane with respect to the base along the major stimulation axis
  • elevation direction e.g., vertically, as viewed from the side, a vertical plane with respect to the base along the major stimulation axis.
  • the light field of view the therapy device 1901 can be the same as or in certain examples specifically greater than both or all aspects of the antenna field of view of the therapy device 1901, including the azimuth direction (e.g., horizontally, as viewed from above, a horizontal plane with respect to the base along the major stimulation axis) as well as the elevation direction (e.g., vertically, as viewed from the side, a vertical plane with respect to the base along the major stimulation axis).
  • the azimuth direction e.g., horizontally, as viewed from above, a horizontal plane with respect to the base along the major stimulation axis
  • the elevation direction e.g., vertically, as viewed from the side, a vertical plane with respect to the base along the major stimulation axis.
  • a therapy device having a base to support the housing on a horizontal surface
  • a wall or ceiling mounted device, or a standing floor lamp device can be anticipated, with the field of view and major stimulation axis relative to an expected location of the user configured to receive the provided stimulation, consistent with the teachings illustrated herein.
  • FIG. 20 illustrates a block diagram of an example machine 2000 upon which any one or more of the techniques (e.g., methodologies) discussed herein may perform. Portions of this description may apply to the computing framework of one or of the components described herein, such as the one or more control circuits, therapy devices, first and second sources, etc. Examples, as described herein, may include, or may operate by, logic or a number of components, or mechanisms in the machine 2000.
  • Circuitry e.g., a control circuit, etc.
  • Circuitry is a collection of circuits implemented in tangible entities of the machine 2000 that include hardware (e.g., simple circuits, gates, logic, etc.). Circuitry membership may be flexible over time. Circuitries include members that may, alone or in combination, perform specified operations when operating. In other examples, circuitry may include a processor.
  • hardware of the circuitry may be immutably designed to carry out a specific operation (e.g., hardwired).
  • the hardware of the circuitry may include variably connected physical components (e.g., execution units, transistors, simple circuits, etc.) including a machine-readable medium physically modified (e.g., magnetically, electrically, moveable placement of invariant massed particles, etc.) to encode instructions of the specific operation.
  • variably connected physical components e.g., execution units, transistors, simple circuits, etc.
  • a machine-readable medium physically modified e.g., magnetically, electrically, moveable placement of invariant massed particles, etc.
  • the instructions enable embedded hardware (e.g., the execution units or a loading mechanism) to create members of the circuitry in hardware via the variable connections to carry out portions of the specific operation when in operation.
  • the machine-readable medium elements are part of the circuitry or are communicatively coupled to the other components of the circuitry when the device is operating.
  • any of the physical components may be used in more than one member of more than one circuitry.
  • execution units may be used in a first circuit of a first circuitry at one point in time and reused by a second circuit in the first circuitry, or by a third circuit in a second circuitry at a different time. Additional examples of these components with respect to the machine 2000 follow.
  • the machine 2000 may operate as a standalone device or may be connected (e.g., networked) to other machines. In a networked deployment, the machine 2000 may operate in the capacity of a server machine, a client machine, or both in server-client network environments. In an example, the machine 2000 may act as a peer machine in peer-to- peer (P2P) (or other distributed) network environment.
  • the machine 2000 may be a personal computer (PC), a tablet PC, a set-top box (STB), a personal digital assistant (PDA), a mobile telephone, a web appliance, a network router, switch or bridge, or any machine capable of executing instructions (sequential or otherwise) that specify actions to be taken by that machine.
  • machine shall also be taken to include any collection of machines that individually or jointly execute a set (or multiple sets) of instructions to perform any one or more of the methodologies discussed herein, such as cloud computing, software as a service (SaaS), other computer cluster configurations.
  • cloud computing software as a service
  • SaaS software as a service
  • the machine 2000 may include a hardware processor 2002 (e.g., a central processing unit (CPU), a graphics processing unit (GPU), a hardware processor core, or any combination thereof), a main memory 2004, a static memory 2006 (e.g., memory or storage for firmware, microcode, a basic-input-output (BIOS), unified extensible firmware interface (UEFI), etc.), and mass storage 2008 (e.g., hard drive, tape drive, flash storage, or other block devices) some or all of which may communicate with each other via an interlink (e.g., bus) 2030.
  • a hardware processor 2002 e.g., a central processing unit (CPU), a graphics processing unit (GPU), a hardware processor core, or any combination thereof
  • main memory 2004 e.g., main memory 2004, a static memory 2006 (e.g., memory or storage for firmware, microcode, a basic-input-output (BIOS), unified extensible firmware interface (UEFI), etc.
  • mass storage 2008 e.g.
  • the machine 2000 may further include a display unit 2010, an alphanumeric input device 2012 (e.g., a keyboard), and a user interface (UI) navigation device 2014 (e.g., a mouse).
  • the display unit 2010, input device 2012, and UI navigation device 2014 may be a touch screen display.
  • the machine 2000 may additionally include a signal generation device 2018 (e.g., a speaker), a network interface device 2020, and one or more sensors 2016, such as a global positioning system (GPS) sensor, compass, accelerometer, or one or more other sensors.
  • GPS global positioning system
  • the machine 2000 may include an output controller 2028, such as a serial (e.g., universal serial bus (USB), parallel, or other wired or wireless (e.g., infrared (IR), near field communication (NFC), etc.) connection to communicate or control one or more peripheral devices (e.g., a printer, card reader, etc.).
  • a serial e.g., universal serial bus (USB), parallel, or other wired or wireless (e.g., infrared (IR), near field communication (NFC), etc.) connection to communicate or control one or more peripheral devices (e.g., a printer, card reader, etc.).
  • USB universal serial bus
  • IR infrared
  • NFC near field communication
  • Registers of the processor 2002, the main memory 2004, the static memory 2006, or the mass storage 2008 may be, or include, a machine-readable medium 2022 on which is stored one or more sets of data structures or instructions 2024 (e.g., software) embodying or utilized by any one or more of the techniques or functions described herein.
  • the instructions 2024 may also reside, completely or at least partially, within any of registers of the processor 2002, the main memory 2004, the static memory 2006, or the mass storage 2008 during execution thereof by the machine 2000.
  • one or any combination of the hardware processor 2002, the main memory 2004, the static memory 2006, or the mass storage 2008 may constitute the machine- readable medium 2022.
  • machine-readable medium 2022 is illustrated as a single medium, the term “machine -readable medium” may include a single medium or multiple media (e.g., a centralized or distributed database, and/or associated caches and servers) configured to store the one or more instructions 2024.
  • machine -readable medium may include a single medium or multiple media (e.g., a centralized or distributed database, and/or associated caches and servers) configured to store the one or more instructions 2024.
  • machine -readable medium may include any medium that is capable of storing, encoding, or carrying instructions for execution by the machine 2000 and that cause the machine 2000 to perform any one or more of the techniques of the present disclosure, or that is capable of storing, encoding, or carrying data structures used by or associated with such instructions.
  • Non-limiting machine-readable medium examples may include solid-state memories, optical media, magnetic media, and signals (e.g., radio frequency signals, other photon-based signals, sound signals, etc.).
  • a non-transitory machine -readable medium comprises a machine-readable medium with a plurality of particles having invariant (e.g., rest) mass, and thus are compositions of matter.
  • non-transitory machine-readable media are machine- readable media that do not include transitory propagating signals.
  • Specific examples of non- transitory machine-readable media may include non-volatile memory, such as semiconductor memory devices (e.g., Electrically Programmable Read-Only Memory (EPROM), Electrically Erasable Programmable Read-Only Memory (EEPROM)) and flash memory devices; magnetic disks, such as internal hard disks and removable disks; magneto-optical disks; and CD-ROM and DVD-ROM disks.
  • the instructions 2024 may be further transmitted or received over a communications network 2026 using a transmission medium via the network interface device 2020 utilizing any one of a number of transfer protocols (e.g., frame relay, internet protocol (IP), transmission control protocol (TCP), user datagram protocol (UDP), hypertext transfer protocol (HTTP), etc.).
  • transfer protocols e.g., frame relay, internet protocol (IP), transmission control protocol (TCP), user datagram protocol (UDP), hypertext transfer protocol (HTTP), etc.
  • Example communication networks may include a local area network (LAN), a wide area network (WAN), a packet data network (e.g., the Internet), mobile telephone networks (e.g., cellular networks), Plain Old Telephone (POTS) networks, and wireless data networks (e.g., Institute of Electrical and Electronics Engineers (IEEE) 802.11 family of standards known as Wi-Fi®, IEEE 802.16 family of standards known as WiMax®), IEEE 802.15.4 family of standards, peer-to-peer (P2P) networks, among others.
  • the network interface device 2020 may include one or more physical jacks (e.g., Ethernet, coaxial, or phone jacks) or one or more antennas to connect to the communications network 2026.
  • the network interface device 2020 may include a plurality of antennas to wirelessly communicate using at least one of single-input multiple-output (SIMO), multiple-input multiple-output (MIMO), or multiple-input single-output (MISO) techniques.
  • SIMO single-input multiple-output
  • MIMO multiple-input multiple-output
  • MISO multiple-input single-output
  • transmission medium shall be taken to include any intangible medium that is capable of storing, encoding, or carrying instructions for execution by the machine 2000, and includes digital or analog communications signals or other intangible medium to facilitate communication of such software.
  • a transmission medium is a machine-readable medium.
  • Method examples described herein can be machine or computer-implemented at least in part. Some examples may include a computer-readable medium or machine-readable medium encoded with instructions operable to configure an electronic device or system to perform methods as described in the examples herein.
  • An implementation of such methods can include code, such as microcode, assembly language code, a higher-level language code, or the like. Such code can include computer readable instructions for performing various methods. The code can form portions of computer program products. Further, the code can be tangibly stored on one or more volatile or non-volatile computer-readable media during execution or at other times. Included below are further examples, each of which may independently define an aspect or embodiment of the invention.
  • Example 1 is a therapy device comprising: a housing; at least one antenna in or on the housing and configured to emit electromagnetic radiation according to an antenna field of view; and one or more light sources in or on the housing configured to emit a visible light according to a light field of view, wherein the at least one antenna and the one or more light sources are positioned in or on the housing to substantially align the antenna field of view and the light field of view to define a directional field of view of the therapy device as being an intersection of the antenna field of view and the light field of view to provide directionally targeted therapy from each of the electromagnetic radiation and the visible light that is additive to a user in the directional field of view of the therapy device.
  • Example 2 the subject matter of Example 1, wherein the antenna field of view has a center defined by a first axis and the light field of view has a center defined by a second axis, wherein the first axis and the second axis are substantially aligned.
  • Example 3 the subject matter of Example 2, comprising: a cover configured to enclose, when engaged with a first surface of the housing, an interior space of the housing, wherein the first axis and the second axis are each substantially normal to an external surface of the cover.
  • Example 4 the subject matter of any of Examples 1-3, wherein the at least one antenna and the one or more light sources are positioned within the housing.
  • Example 5 the subject matter of any of Examples 1-4, wherein the at least one antenna generates the electromagnetic radiation to have a front-to-back power ratio of at least 10.
  • Example 6 the subject matter of any of Examples 1-5, wherein the antenna field of view comprises a horizontal field of view, when the therapy device is configured for use, that is at least 90 degrees.
  • Example 7 the subject matter of any of Examples 1-6, wherein the intersection of the antenna field of view and the light field of view is an intersection of both a horizontal field of view and a vertical field of view when the therapy device is configured for use.
  • Example 8 the subject matter of any of Examples 1-7, wherein the therapy device has a base for sitting or mounting the therapy device in an orientation in which the intersection of the antenna field of view and the light field of view is an intersection of both a horizontal field of view and a vertical field of view when the therapy device is configured for use.
  • Example 9 the subject matter of any of Examples 1-8, wherein the directional field of view of the therapy device has a center that defines a major stimulation axis of the therapy device.
  • Example 10 the subject matter of Example 9, wherein the antenna field of view in any angular direction is defined by a half power beamwidth (HPBW) of the at least one antenna in that angular direction, with respect to a major lobe of the at least one antenna.
  • HPBW half power beamwidth
  • Example 11 the subject matter of any of Examples 1-10, wherein the light field of view has a horizontal field of view that is at least as wide as a horizontal field of view of the antenna field of view to indicate that a position outside of the horizontal field of view of the light field of view is outside of the horizontal field of view of the antenna field of view.
  • Example 12 the subject matter of Example 11, wherein the antenna field of view is less than the light field of view with respect to a vertical field of view of the therapy device.
  • Example 13 the subject matter of any of Examples 1-12, wherein the housing comprises a base to support the housing, wherein the therapy device comprises a cover comprising a translucent portion substantially perpendicular to the base, wherein substantially perpendicular comprises within 20 degrees of perpendicular, wherein the cover comprises one or more surface features configured to diffuse light passing through the translucent portion of the cover.
  • Example 14 the subject matter of Example 13, wherein the directional field of view of the therapy device has a center defined by a therapy axis that is substantially normal to a major surface of the cover, wherein substantially normal comprises within 5 degrees of normal.
  • Example 15 the subject matter of any of Examples 1-14, comprising: one or more control circuits configured to control concurrent generation of the electromagnetic radiation and the visible light; and one or more signal generators configured to provide signals to the at least one antenna to generate electromagnetic radiation or to the one or more light sources to generate visible light.
  • Example 16 the subject matter of any of Examples 1-15, comprising a printed circuit board (PCB) positioned in the housing, wherein the at least one antenna comprises a patch antenna printed at a central location of the PCB, wherein the one or more light sources comprises a plurality of light sources positioned on the PCB about the patch antenna.
  • PCB printed circuit board
  • Example 17 is a therapy device comprising: a housing having a first surface; an antenna in or on the housing configured to emit electromagnetic radiation substantially normal to and out of the first surface; and one or more light sources in or on the housing configured to emit a visible light substantially normal to and out of the first surface, wherein the antenna and the one or more light sources are positioned in the housing to substantially align emitted electromagnetic radiation from the antenna with emitted visible light from the one or more light sources to apply the substantially aligned emitted electromagnetic radiation and visible light to a user in a field of view of the therapy device, the field of view of the therapy device comprising the substantially aligned emitted electromagnetic radiation from the antenna and visible light from the one or more light sources.
  • Example 18 the subject matter of Example 17, comprising a cover configured to enclose, when engaged at or with the housing, an interior space of the housing, wherein the first surface comprises a major exterior surface of the cover, wherein the antenna is configured to emit electromagnetic radiation having a major lobe substantially normal to and out of the first surface of the cover, and wherein the one or more light sources are configured to emit the visible light having a principal axis substantially normal to and out of the surface of the cover,
  • Example 19 the subject matter of Example 18, wherein the major lobe of the antenna and the principal axis of the one or more light sources define a major stimulation axis of the therapy device, wherein the antenna comprises an antenna field of view and the one or more light sources comprise a light field of view.
  • Example 20 the subject matter of Example 19, wherein the antenna field of view in any angular direction is defined by a half power beamwidth (HPBW) of the antenna in that angular direction with respect to the major lobe of the antenna.
  • HPBW half power beamwidth
  • Example 21 the subject matter of any of Examples 19-20, wherein a field of view of the therapy device comprises at least one of the antenna field of view or the light field of view, wherein to provide the additive therapeutic effect to the user exposed to the electromagnetic radiation and the visible light comprises to provide the additive therapeutic effect to the user positioned within the field of view of the therapy device.
  • Example 22 the subject matter of any of Examples 19-21, wherein a central axis of the antenna field of view and a central axis of the light field of view are within a threshold tolerance with respect to a horizontal plane of the major stimulation axis of the therapy device, wherein the threshold tolerance is 20 degrees.
  • Example 23 the subject matter of any of Examples 19-22, wherein the light field of view has a horizontal field of view that is at least as wide as a horizontal field of view of the antenna field of view to indicate that a position outside of the horizontal field of view of the light field of view is outside of the horizontal field of view of the antenna field of view.
  • Example 24 the subject matter of Example 23, wherein the antenna field of view is less than the light field of view with respect to a vertical field of view of the therapy device.
  • Example 25 the subject matter of any of Examples 19-24, wherein the housing comprises a base to support the housing, wherein the cover comprises a translucent portion substantially perpendicular to the base, wherein substantially perpendicular comprises within 20 degrees of perpendicular, wherein the cover comprises one or more surface features configured to diffuse light passing through the translucent portion of the cover.
  • Example 26 the subject matter of Example 25, wherein the field of view of the therapy device has a center defined by a therapy axis that is substantially normal to a major surface of the cover, wherein substantially normal comprises within 5 degrees of normal.
  • Example 27 the subject matter of any of Examples 19-26, comprising: one or more control circuits configured to control concurrent generation of the electromagnetic radiation and the visible light; and one or more signal generators configured to provide signals to the antenna to generate electromagnetic radiation or to the one or more light sources to generate visible light.
  • Example 28 the subject matter of any of Examples 19-27, comprising a printed circuit board (PCB) positioned in the housing, wherein the antenna comprises a patch antenna printed at a central location of the PCB, wherein the one or more light sources are positioned on the PCB in a substantially uniform distribution about the patch antenna.
  • PCB printed circuit board
  • Example 29 is a method comprising: positioning at least one antenna and one or more light sources in or on a housing of a therapy device to substantially align an antenna field of view and a light field of view to define a directional field of view of the therapy device as being an intersection of the antenna field of view and the light field of view to provide directionally targeted therapy from each of electromagnetic radiation from the antenna field of view and a visible light from the light field of view that is additive to a user in the directional field of view of the therapy device; emitting, using the at least one antenna, the electromagnetic radiation according to the antenna field of view; and emitting, using the one or more light sources, the visible light according to the light field of view.
  • Example 30 the subject matter of Example 29, wherein the antenna field of view has a center defined by a first axis and the light field of view has a center defined by a second axis, wherein the first axis and the second axis are substantially aligned.
  • Example 31 the subject matter of Example 30, comprising enclosing an interior space of the housing with a cover, wherein the first axis and the second axis are each substantially normal to an external surface of the cover.
  • Example 32 the subject matter of any of Examples 29-31, wherein the at least one antenna and the one or more light sources are positioned within the housing.
  • Example 33 the subject matter of any of Examples 29-32, wherein emitting the electromagnetic radiation comprises emitting electromagnetic radiation having a front-to-back power ratio of at least 10.
  • Example 34 the subject matter of any of Examples 29-33, wherein the antenna field of view comprises a horizontal field of view, when the therapy device is configured for use, that is at least 90 degrees.
  • Example 35 the subject matter of any of Examples 29-34, wherein the intersection of the antenna field of view and the light field of view is an intersection of both a horizontal field of view and a vertical field of view when the therapy device is configured for use.
  • Example 36 the subject matter of any of Examples 29-35, comprising sitting or mounting the therapy device in an orientation using a base in which the intersection of the antenna field of view and the light field of view is an intersection of both a horizontal field of view and a vertical field of view when the therapy device is configured for use.
  • Example 37 the subject matter of any of Examples 29-36, wherein the directional field of view of the therapy device has a center that defines a major stimulation axis of the therapy device.
  • Example 38 the subject matter of Example 37, wherein the antenna field of view in any angular direction is defined by a half power beamwidth (HPBW) of the at least one antenna in that angular direction, with respect to a major lobe of the at least one antenna.
  • HPBW half power beamwidth
  • Example 39 the subject matter of any of Examples 29-38, wherein the light field of view has a horizontal field of view that is at least as wide as a horizontal field of view of the antenna field of view to indicate that a position outside of the horizontal field of view of the light field of view is outside of the horizontal field of view of the antenna field of view.
  • Example 40 the subject matter of Example 39, wherein the antenna field of view is less than the light field of view with respect to a vertical field of view of the therapy device.
  • Example 41 the subject matter of any of Examples 29-40, comprising: supporting the housing using a base; and diffusing emitted light using one or more surface features of a translucent portion of a cover substantially perpendicular to the base, wherein substantially perpendicular comprises within 20 degrees of perpendicular.
  • Example 42 the subject matter of Example 41, wherein the directional field of view of the therapy device has a center defined by a therapy axis that is substantially normal to a major surface of the cover, wherein substantially normal comprises within 5 degrees of normal.
  • Example 43 the subject matter of any of Examples 29-42, comprising: controlling concurrent generation of the electromagnetic radiation and the visible light using one or more control circuits; and providing signals to the at least one antenna to generate electromagnetic radiation or to the one or more light sources to generate visible light using one or more signal generators.
  • Example 44 the subject matter of any of Examples 29-43, wherein positioning the at least one antenna comprises positioning a patch antenna at a central location of a printed circuit board (PCB) in the housing, wherein positioning the one or more light sources comprises positioning a plurality of light sources on the PCB about the patch antenna.
  • PCB printed circuit board
  • Example 45 is a method comprising: positioning an antenna and one or more light sources in or on a housing of a therapy device to substantially align emitted electromagnetic radiation from the antenna with emitted visible light from the one or more light sources substantially normal to and out of a first surface of the housing to provide electromagnetic radiation and emitted visible light to a user in a field of view of the therapy device, the field of view comprising the substantially aligned emitted electromagnetic radiation from the antenna and visible light from the one or more light sources; emitting, using the antenna, the electromagnetic radiation substantially normal to and out of the first surface; and emitting, using the one or more light sources, the visible light substantially normal to and out of the first surface.
  • Example 46 the subject matter of Example 45, comprising enclosing an interior space of the housing using a cover, wherein the first surface comprises a major exterior surface of the cover, wherein emitting the electromagnetic radiation comprises emitting the electromagnetic radiation having a major lobe substantially normal to and out of the first surface of the cover, and wherein emitting the visible light comprises emitting the visible light having a principal axis substantially normal to and out of the surface of the cover,
  • Example 47 the subject matter of Example 46, wherein the major lobe of the antenna and the principal axis of the one or more light sources define a major stimulation axis of the therapy device, wherein the antenna comprises an antenna field of view and the one or more light sources comprise a light field of view.
  • Example 49 the subject matter of any of Examples 47-48, wherein a field of view of the therapy device comprises at least one of the antenna field of view or the light field of view, wherein positioning the antenna and the one or more light sources in or one the housing to substantially align the major lobe of the antenna with the principal axis of the one or more light sources to provide an additive therapeutic effect to the user exposed to the electromagnetic radiation and the visible light comprises providing the additive therapeutic effect to the user positioned within the field of view of the therapy device.
  • Example 50 the subject matter of any of Examples 47-49, wherein the antenna field of view and the light field of view are within a threshold tolerance with respect to a horizontal plane of the major stimulation axis of the therapy device, wherein the threshold tolerance is 20 degrees.
  • Example 51 the subject matter of any of Examples 47-50, wherein the light field of view has a horizontal field of view that is at least as wide as a horizontal field of view of the antenna field of view to indicate that a position outside of the horizontal field of view of the light field of view is outside of the horizontal field of view of the antenna field of view.
  • Example 52 the subject matter of Example 51, wherein the antenna field of view is less than the light field of view with respect to a vertical field of view of the therapy device.
  • Example 53 the subject matter of any of Examples 47-52, comprising: supporting the housing using a base; and diffusing emitted light using one or more surface features of a translucent portion of a cover substantially perpendicular to the base, wherein substantially perpendicular comprises within 20 degrees of perpendicular.
  • Example 54 the subject matter of Example 53, wherein the field of view of the therapy device has a center defined by a therapy axis that is substantially normal to a major surface of the cover, wherein substantially normal comprises within 5 degrees of normal.
  • Example 55 the subject matter of any of Examples 47-54, comprising: controlling concurrent generation of the electromagnetic radiation and the visible light using one or more control circuits; and providing signals to the antenna to generate electromagnetic radiation or to the one or more light sources to generate visible light using one or more signal generators.
  • Example 56 the subject matter of any of Examples 47-55, wherein positioning the antenna comprises positioning a patch antenna at a central location of a printed circuit board (PCB) in the housing, wherein positioning the one or more light sources comprises positioning a plurality of light sources on the PCB about the patch antenna.
  • PCB printed circuit board
  • Example 57 is a system, comprising: one or more control circuits configured to receive user information and to determine first and second output signals based at least in part on the received user information; a first source configured to generate a first therapy output based at least in part on the determined first output signal, wherein the first source includes an electromagnetic wave generator and the first therapy output includes a non-visible electromagnetic wave output; and a second source configured to generate a second therapy output based at least in part on the determined second output signal, wherein the second source includes a light generator and the second therapy output includes a visible light output, wherein the one or more control circuits are configured to control concurrent generation of the first and second therapy outputs for a treatment interval and adjustment of the first and second therapy outputs at one or more intermediate time periods of the treatment interval based at least in part on the received user information.
  • Example 58 the subject matter of Example 57, wherein the user information includes an indication of a selection from the user of one of a plurality of available programs for electromagnetic and light therapy.
  • Example 59 the subject matter of Example 58, comprising: a memory circuit to store the plurality of available programs for electromagnetic and light therapy, wherein the one or more control circuits are configured to receive the selected program from the memory circuit and to provide the selected program to the first and second sources.
  • Example 60 the subject matter of any of Examples 57-59, wherein the user information includes a selection of a color by a patient, wherein the one or more control circuits are configured to determine the first and second output signals based on the selected color.
  • Example 61 the subject matter of any of Examples 57-60, wherein the first therapy output is dependent on the second therapy output, wherein changes in the visible light output are concurrent with changes in the non-visible electromagnetic wave output.
  • Example 62 the subject matter of any of Examples 57-61, wherein the user information includes one of a planned sleep time or a planned wake time of a patient.
  • the treatment interval comprises a sleep interval and a preparation interval, wherein a transition from the preparation interval to the sleep interval is an end of an intermediate time period, wherein adjustment of the first and second therapy outputs includes concurrent adjustment of the first and second therapy outputs at the transition from the preparation interval to the sleep interval.
  • Example 64 the subject matter of Example 63, wherein, during the sleep interval, prior to a subsequent wakening or an awake interval, the one or more control circuits are configured to adjust the non-visible electromagnetic wave output while maintaining the visible light output to a specific visible color output.
  • Example 65 the subject matter of any of Examples 57-64, wherein the one or more control circuits are configured to control concurrent transition of the first and second outputs from a first frequency to a second frequency at a first intermediate time period.
  • Example 66 the subject matter of any of Examples 57-65, wherein the first generator includes an antenna configured to emit the non-visible electromagnetic wave output.
  • Example 67 the subject matter of any of Examples 57-66, wherein the second generator includes a light source configured to emit a visible light.
  • Example 68 the subject matter of any of Examples 57-67, wherein the non-visible electromagnetic wave output includes a representation of a brain wave recorded from a patient or one or more other individuals.
  • Example 69 the subject matter of any of Examples 57-68, wherein the one or more control circuits are configured to control adjustment of the non-visible electromagnetic wave output based on a time of brain wave transitions of a patient.
  • Example 70 the subject matter of any of Examples 57-69, wherein the one or more control circuits are configured to determine at least one of a start time or a duration of the treatment interval based at least in part on the received user information.
  • Example 71 the subject matter of any of Examples 57-70, wherein to control adjustment of the first and second therapy outputs includes to control concurrent adjustment of the first and second therapy outputs at one or more of the intermediate time periods of the treatment interval.
  • Example 72 the subject matter of any of Examples 57-71, wherein the first source is configured to generate the first therapy output based at least in part on a stimulation waveform having a characteristic including a frequency or a range of frequencies, wherein the second source is configured to generate the second therapy output signal based at least in part on the stimulation waveform having the characteristic including the frequency or the range of frequencies.
  • Example 73 is a method, comprising: receiving user information using one or more control circuits; determining, using the one or more control circuits, first and second output signals based at least in part on the received user information; and controlling, using the one or more control circuits, concurrent generation of first and second therapy outputs by first and second sources for a treatment interval and adjustment of the first and second therapy outputs at one or more intermediate time periods of the treatment interval based at least in part on the received user information, wherein the first source includes an electromagnetic wave generator and the first therapy output includes a non-visible electromagnetic wave output, wherein the second source includes a light generator and the second therapy output includes a visible light output.
  • Example 74 the subject matter of Example 73, wherein receiving user information includes receiving an indication of a selection from the user of one of a plurality of available programs for electromagnetic and light therapy.
  • Example 75 the subject matter of Example 74, comprising: storing, using a memory circuit, the plurality of available programs for electromagnetic and light therapy, wherein receiving the indication of the selection comprises receiving the selected program from the memory circuit, wherein controlling concurrent generation of the first and second therapy outputs comprises providing the selected program to the first and second sources.
  • Example 76 the subject matter of any of Examples 73-75, wherein receiving user information includes a receiving a selection of a color by a patient, wherein determining the first and second output signals comprises determining the first and second output signals based on the selected color.
  • Example 77 the subject matter of any of Examples 73-76, wherein the first therapy output is dependent on the second therapy output, wherein changes in the visible light output are concurrent with changes in the non-visible electromagnetic wave output.
  • Example 78 the subject matter of any of Examples 73-77, wherein receiving user information includes receiving one of a planned sleep time or a planned wake time of a patient.
  • Example 79 the subject matter of Example 78, wherein the treatment interval comprises a sleep interval and a preparation interval, wherein a transition from the preparation interval to the sleep interval is an end of an intermediate time period, wherein controlling adjustment of the first and second therapy outputs includes controlling concurrent adjustment of the first and second therapy outputs at the transition from the preparation interval to the sleep interval.
  • Example 80 the subject matter of Example 79, wherein controlling adjustment of the first and second therapy outputs at one or more intermediate time periods of the treatment interval comprises adjusting, during the sleep interval, prior to a subsequent wakening or an awake interval, the non- visible electromagnetic wave output while maintaining the visible light output to a specific visible color output.
  • Example 81 the subject matter of any of Examples 73-80, wherein controlling adjustment of the first and second therapy outputs comprises controlling concurrent transition of the first and second outputs from a first frequency to a second frequency at a first intermediate time period.
  • Example 82 the subject matter of any of Examples 73-81, wherein controlling generation of the first therapy output comprises using a representation of a brain wave recorded from a patient or one or more other individuals.
  • Example 83 the subject matter of any of Examples 73-82, wherein controlling concurrent generation of the first and second therapy outputs comprises determine at least one of a start time or a duration of the treatment interval based at least in part on the received user information.
  • Example 84 the subject matter of any of Examples 73-83, wherein controlling adjustment of the first and second therapy outputs includes controlling concurrent adjustment of the first and second therapy outputs at one or more of the intermediate time periods of the treatment interval.
  • Example 85 the subject matter of any of Examples 73-84, comprising: generating, using the first source, the first therapy output based at least in part on the determined first output signal; and generating, using the second source, the second therapy output based at least in part on the determined second output signal.
  • Example 86 the subject matter of Example 85, wherein generating the first therapy output comprises generating the first therapy output based at least in part on a first waveform having a first characteristic including a first frequency or a first range of frequencies, wherein generating the second therapy output comprises generating the second therapy output based at least in part on the first waveform having the first characteristic including the first frequency or the first range of frequencies.
  • Example 87 is a system, comprising: one or more control circuits configured to receive user information and to determine first and second output signals based at least in part on the received user information; a first source configured to generate a first therapy output based at least in part on the determined first output signal, wherein the first source includes an electromagnetic wave generator and the first therapy output includes a non-visible electromagnetic wave output; and a second source configured to generate a second therapy output based at least in part on the determined second output signal, wherein the second source includes a light generator and the second therapy output includes a visible light output, wherein the one or more control circuits are configured to control concurrent generation of the first and second therapy outputs for a treatment interval and adjustment of the first and second therapy outputs at one or more intermediate time periods of the treatment interval based at least in part on the received user information, wherein the treatment interval includes a sleep interval and a preparation interval, wherein a transition from the preparation interval to the sleep interval is an end of an intermediate time period, wherein to control adjustment of the first and second therapy outputs at one
  • Example 88 the subject matter of Example 87, wherein to determine the treatment interval, the one or more control circuits are configured to determine a start time of the treatment interval based at least in part on the received user information.
  • Example 89 is a system, comprising: one or more control circuits configured to receive user information and to determine first and second parameters of a therapy output based at least in part on the received user information, the first parameter including a color and the second parameter including a stimulation waveform for generating the therapy output; and one or more therapy sources configured to generate the therapy output based at least in part on the determined first and second parameters, wherein the one or more control circuits are configured to control generation of the therapy output to concurrently have characteristics corresponding to the first and second parameters for a treatment interval.
  • Example 90 the subject matter of Example 89, wherein the therapy output includes a visible output based on the determined first parameter and a non-visible output based on the determined second parameter, wherein the one or more control circuits are configured to control concurrent generation of the visible and non-visible outputs for the treatment interval based at least in part on the received user information.
  • the one or more control circuits are configured to generate a modulated output signal using the stimulation waveform including changes outside of a visible range perceptible to a human eye
  • the one or more therapy sources includes a light generator configured to generate the visible output corresponding to the first parameter and the non- visible output corresponding to the second parameter using the modulated output signal.
  • Example 92 the subject matter of any of Examples 90-91, wherein the one or more therapy sources includes: a first source configured to generate the visible output corresponding to the determined first parameter; and a second source configured to generate the non-visible output corresponding to the determined second parameter.
  • Example 93 the subject matter of Example 92, wherein the first source includes a light generator and the visible output includes a visible light output, wherein the second source includes an electromagnetic wave generator and the non-visible output includes a non-visible electromagnetic wave output.
  • Example 94 the subject matter of Example 93, wherein the one or more control circuits are configured to control generation of the color of the visible light output of the light generator using the received user information and to control generation of the non-visible electromagnetic wave output based on the determined color.
  • Example 95 the subject matter of any of Examples 89-94, wherein the second parameter includes the stimulation waveform having a characteristic including a frequency or a range of frequencies, wherein to determine the first and second parameters includes to select the color from a plurality of colors and to select the frequency or the range of frequencies from at least one of a plurality of frequencies or a plurality of ranges of frequencies.
  • Example 96 the subject matter of Example 95, wherein the one or more control circuits are configured to determine the first and second parameters based at least in part on the received user information and a predetermined relationship between the first and second parameters.
  • Example 97 the subject matter of Example 96, wherein the predetermined relationship includes a defined correlation between the selected color and the selected frequency or the range of frequencies.
  • Example 98 the subject matter of any of Examples 96-97, wherein the one or more control circuits are configured to determine one of the first and second parameters based on the received user information and the other of the first and second parameters using the predetermined relationship between the first and second parameters.
  • Example 99 the subject matter of any of Examples 96-98, wherein the therapy output includes first and second therapy outputs, wherein the one or more therapy sources include a first source configured to generate the first therapy output and a second source configured to generate the second therapy output, wherein the first source is configured to generate the first therapy output corresponding to the determined first parameter and modulated by the second parameter including the stimulation waveform having the characteristic including the frequency or the range of frequencies, wherein the second source is configured to generate the second therapy output including a carrier wave modulated by the second parameter including the stimulation waveform having the characteristic including the frequency or the range of frequencies.
  • the one or more therapy sources include a first source configured to generate the first therapy output and a second source configured to generate the second therapy output, wherein the first source is configured to generate the first therapy output corresponding to the determined first parameter and modulated by the second parameter including the stimulation waveform having the characteristic including the frequency or the range of frequencies, wherein the second source is configured to generate the second therapy output including a carrier wave modulated by the second parameter including the stimulation waveform having the characteristic
  • Example 100 the subject matter of Example 99, wherein the first source includes a light generator and the first therapy output includes a visible light output modulated by the second parameter, wherein the second source includes an electromagnetic wave generator and second therapy output includes a non-visible electromagnetic wave output modulated by the second parameter.
  • Example 101 is a method, comprising: receiving user information using one or more control circuits; determining, using the one or more control circuits, first and second parameters of a therapy output based at least in part on the received user information, the first parameter including a color and the second parameter including a stimulation waveform for generating the therapy output; and controlling generation of the therapy output, using the one or more control circuits, to concurrently have characteristics corresponding to the first and second parameters for a treatment interval.
  • Example 102 the subject matter of Example 101, comprising generating the therapy output, using one or more therapy sources, based at least in part on the determined first and second parameters.
  • Example 103 the subject matter of Example 102, wherein the therapy output includes a visible output based on the determined first parameter and a non-visible output based on the determined second parameter, wherein controlling generation of the therapy output comprises controlling concurrent generation of the visible and non-visible outputs for the treatment interval based at least in part on the received user information.
  • Example 104 the subject matter of Example 103, comprising generating a modulated output signal using the stimulation waveform including changes outside of a visible range perceptible to a human eye, wherein generating the therapy output comprises generating, using a light generator, the visible output corresponding to the first parameter and the non-visible output corresponding to the second parameter using the modulated output signal.
  • Example 105 the subject matter of any of Examples 103-104, wherein generating the therapy output using one or more therapy sources comprises: generating the visible output corresponding to the determined first parameter using a first source; and generating the non-visible output corresponding to the determined second parameter using a second source.
  • Example 106 the subject matter of Example 105, wherein the first source includes a light generator and the visible output includes a visible light output, wherein the second source includes an electromagnetic wave generator and the non-visible output includes a non-visible electromagnetic wave output.
  • Example 107 the subject matter of Example 106, wherein controlling generation of the color of the visible light output of the light generator comprises using the received user information, wherein controlling generation of the non-visible electromagnetic wave output comprises based on the determined color.
  • Example 108 the subject matter of any of Examples 102-107, wherein the second parameter includes a frequency or a range of frequencies, wherein determining the first and second parameters includes selecting the color from a plurality of colors and selecting the frequency or the range of frequencies from at least one of a plurality of frequencies or a plurality of ranges of frequencies based at least in part on the received user information.
  • Example 109 the subject matter of Example 108, wherein determining the first and second parameters comprises based at least in part on the received user information and a predetermined relationship between the first and second parameters.
  • Example 110 the subject matter of Example 109, wherein the predetermined relationship includes a defined correlation between the selected color and the selected frequency or the range of frequencies.
  • Example 111 the subject matter of any of Examples 109-110, wherein determining the first and second parameters comprises determining one of the first and second parameters based on the received user information and the other of the first and second parameters using the predetermined relationship between the first and second parameters.
  • generating the therapy output using the one or more therapy sources comprises: generating a first therapy output corresponding to the determined first parameter and modulated by the second parameter including the frequency or the range of frequencies using a first source; and generating a second therapy output including a carrier wave modulated by the second parameter including the frequency or the range of frequencies using a second source.
  • Example 113 the subject matter of Example 112, wherein the first source includes a light generator and the first therapy output includes a visible light output modulated by the second parameter, wherein the second source includes an electromagnetic wave generator and the second output includes a non- visible electromagnetic wave output modulated by the second parameter.
  • Example 114 is a system comprising: one or more control circuits configured to receive user information and to determine first and second parameters of a therapy output based at least in part on the received user information, wherein the first parameter includes a stimulation waveform having a characteristic including a frequency or a range of frequencies and the second parameter includes a color; a first source configured to generate a first therapy output based at least in part on the determined first parameter, wherein the first source includes an electromagnetic wave generator and the first therapy output includes a non- visible electromagnetic wave output; and a second source configured to generate a second therapy output based at least in part on the determined first and second parameters, wherein the second source includes a light generator and the second therapy output includes a visible light output, wherein the one or more control circuits are configured to control generation of the first therapy output and the second therapy output concurrently having characteristics respectively corresponding to the first parameter and to the first and second parameters for a treatment interval.
  • the first parameter includes a stimulation waveform having a characteristic including a frequency or a range of frequencies and the second parameter
  • Example 115 the subject matter of Example 114, wherein the first source is configured to generate the first therapy output including a carrier wave modulated by the first parameter, wherein the second source is configured to generate the second therapy output corresponding to the second parameter and modulated by the first parameter.
  • Example 116 is a method comprising: receiving user information using one or more control circuits; determining, using the one or more control circuits, first and second parameters of a therapy output based at least in part on the received user information, wherein the first parameter includes a stimulation waveform having a characteristic including a frequency or a range of frequencies and the second parameter includes a color; and controlling generation of a first therapy output based at least in part on the determined first parameter and a second therapy output based at least in part on the determined first and second parameters to concurrently have characteristics respectively corresponding to the first parameter and to the first and second parameters for a treatment interval.
  • Example 117 the subject matter of Example 116, comprising: generating, using a first source, the first therapy output based at least in part on the determined first parameter, wherein the first source includes an electromagnetic wave generator and the first therapy output includes a non-visible electromagnetic wave output; and generating, using a second source, the second therapy output based at least in part on the determined first and second parameters, wherein the second source includes a light generator and the second therapy output includes a visible light output.
  • Example 118 the subject matter of Example 117, wherein the first therapy output comprises a carrier wave modulated by the first parameter, wherein the second therapy output comprises the visible light output, corresponding to the second parameter, modulated by the first parameter.
  • Example 119 is at least one machine-readable medium including instructions that, when executed by processing circuitry, cause the processing circuitry to perform operations to implement of any of Examples 1-118.
  • Example 120 is an apparatus comprising means to implement of any of Examples 1- 118.
  • Example 121 is a system to implement of any of Examples 1-118.
  • Example 122 is a method to implement of any of Examples 1-118.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Social Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Developmental Disabilities (AREA)
  • Child & Adolescent Psychology (AREA)
  • General Business, Economics & Management (AREA)
  • Business, Economics & Management (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Radiation-Therapy Devices (AREA)

Abstract

L'invention concerne des systèmes et des procédés pour fournir et aligner sensiblement la lumière émise et le rayonnement électromagnétique à l'aide d'un dispositif de thérapie comprenant au moins une antenne placée dans ou sur un boîtier et conçue pour émettre un rayonnement électromagnétique selon un champ de vision d'antenne et une ou plusieurs sources de lumière placées dans ou sur le boîtier et conçues pour émettre une lumière visible selon un champ de vision de lumière.
PCT/IL2024/050963 2023-09-29 2024-09-27 Thérapie par champ électromagnétique et lumière directionnelle Pending WO2025069033A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363586761P 2023-09-29 2023-09-29
US63/586,761 2023-09-29

Publications (1)

Publication Number Publication Date
WO2025069033A1 true WO2025069033A1 (fr) 2025-04-03

Family

ID=95202851

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2024/050963 Pending WO2025069033A1 (fr) 2023-09-29 2024-09-27 Thérapie par champ électromagnétique et lumière directionnelle

Country Status (1)

Country Link
WO (1) WO2025069033A1 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060271024A1 (en) * 2005-01-25 2006-11-30 Michael Gertner Nasal Cavity Treatment Apparatus
US20070208395A1 (en) * 2005-10-05 2007-09-06 Leclerc Norbert H Phototherapy Device and Method of Providing Phototherapy to a Body Surface
US20100262135A1 (en) * 2009-04-14 2010-10-14 Primaeva Medical, Inc. Controlled delivery of therapeutic energy to tissue
WO2012129509A2 (fr) * 2011-03-24 2012-09-27 John Martinez Dispositif de thérapie électromagnétique de semelle intérieure
US20140148753A1 (en) * 2012-11-26 2014-05-29 Boston Scientific Neuromodulation Corporation Systems and methods for making and using an electrical stimulation system with photonic stimulation capabilities
US20160220842A1 (en) * 2008-03-03 2016-08-04 DePuy Synthes Products, Inc. Method of Treating Traumatic Brain Injury with Red/NIR Light

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060271024A1 (en) * 2005-01-25 2006-11-30 Michael Gertner Nasal Cavity Treatment Apparatus
US20070208395A1 (en) * 2005-10-05 2007-09-06 Leclerc Norbert H Phototherapy Device and Method of Providing Phototherapy to a Body Surface
US20160220842A1 (en) * 2008-03-03 2016-08-04 DePuy Synthes Products, Inc. Method of Treating Traumatic Brain Injury with Red/NIR Light
US20100262135A1 (en) * 2009-04-14 2010-10-14 Primaeva Medical, Inc. Controlled delivery of therapeutic energy to tissue
WO2012129509A2 (fr) * 2011-03-24 2012-09-27 John Martinez Dispositif de thérapie électromagnétique de semelle intérieure
US20140148753A1 (en) * 2012-11-26 2014-05-29 Boston Scientific Neuromodulation Corporation Systems and methods for making and using an electrical stimulation system with photonic stimulation capabilities

Similar Documents

Publication Publication Date Title
US11013883B2 (en) Stress reduction and sleep promotion system
US7141028B2 (en) Apparatus, system, and method for creating an individually, balanceable environment of sound and light
US11202882B2 (en) System and method for facilitating wakefulness
US20210386964A1 (en) Smart platform for stress reduction and sleep promotion
US7846084B2 (en) Apparatus, system, and method for creating an individually balanceable environment of sound and light
KR20210113266A (ko) 경피 진동을 위한 파 생성 시스템들 및 방법들
JP6924859B2 (ja) 医薬、並びに人体の経絡、臓器及び組織に関連して刺激を生成するためのシステム
US12478760B2 (en) Systems and methods for user entrainment
WO2019175289A1 (fr) Dispositif de champ électromagnétique pulsé et procédé de traitement
JP2020534118A (ja) ストレス低減及び睡眠促進システム
US20160136442A1 (en) Medical device with personalized therapy protocols
CN215024707U (zh) 一种情绪智能调节系统
KR102169133B1 (ko) 수면 유도 장치
JP2018512049A (ja) 周波刺激機器
CN106730237A (zh) 一种情绪调节装置及系统
WO2025069033A1 (fr) Thérapie par champ électromagnétique et lumière directionnelle
WO2025069032A1 (fr) Lumière et thérapie par champ électromagnétique
JP2015502813A (ja) 照明信号、システム、および方法
TWI713806B (zh) 光源裝置以及穿戴式裝置
EP2905544A1 (fr) Hotte de cuisine pour la photothérapie comprenant une source lumineuse à éclairage élevé
TWM587040U (zh) 可對應人體經絡、器官組織及藥物產生刺激的系統
CN201676403U (zh) 一种脑电波调节仪
WO2023038984A1 (fr) Système et procédé pour fournir une expérience de stimulus lumineux et/ou sonore basé sur le contexte
CN215489271U (zh) 一种生物能量管理的护眼灯
KR20230158655A (ko) 광 자극에 의한 생체 기능 제어 장치 및 그의 작동 방법

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24871197

Country of ref document: EP

Kind code of ref document: A1